Live financial news intelligence

Track market-moving stories before they get noisy

Real-time pulse of financial headlines curated from 5 premium feeds.

Latest market signal English
Coverage 169,621 Raw stories ingested 22,421 rewritten in CS_CZ • 0 to rewrite (last 2 days).
Agents 7 waiting Pipeline agents
  • FMP Stock News Fetch every minute 46s ago
  • FMP Forex News Fetch every 5 min 4m ago
  • CoinGecko News Fetch every 5 min 1m ago
  • FIO Stock News Fetch every 10 min 46s ago
  • Patria Stock News Fetch every 10 min 46s ago
  • Editorial rewrite Rewrite every minute 46s ago
  • Asset sync Assets every 1 hour 19m ago

Latest coverage

Market News Feed

Scan headlines quickly, then expand any story for source context.

View
Clear
Details Date Content Source
2026-06-12 14:19 2mo ago
2026-06-08 11:22 3mo ago
Century Complete Reveals New Homes Now Selling in Freeland, MI
CCS Century Communities
FMP Stock News
Original source text
Online homebuying pioneer offers modern floor plans in prime Tri-Cities location. "Dusty Boots" tour of under-construction homes scheduled for June 13.

, /PRNewswire/ -- Century Communities, Inc. (NYSE: CCS)—a top national homebuilder, industry leader in online home sales, and featured on America's Most Trustworthy Companies by Newsweek—announced that the Company's Century Complete brand is now selling new Freeland, MI, homes in a prime location near Midland, Saginaw and Bay City.

Essex Floor Plan Exterior Rendering | New Construction Homes in Freeland, MI | Quail Hollow by Century Complete

Nandina Floor Plan Exterior Rendering | New Homes in Freeland, MI | Quail Hollow by Century Complete "Quail Hollow offers an attractive variety of one- and two-story floor plans—complete with basements—that are designed to enhance modern living and provide long-term value," said Regional President Steve Karhnak. "It's the perfect time to explore available homes and find your best fit."

A "Dusty Boots" tour of under-construction homes will take place at Quail Hollow on Saturday, June 13, from 10 a.m. to 3 p.m. at 9267 Silent Breeze Drive, Freeland, MI 48623.

Learn more and RSVP for the Dusty Boots event at www.CenturyCommunities.com/QuailHollowMI.

Floor plans at Quail Hollow offer up to 2,014 square feet and four bedrooms. One- and two-story options showcase desirable included features such as LG® stainless-steel appliances, quartz countertops, Kohler® fixtures, and luxury vinyl plank flooring. All floor plans will also come with basements.

QUAIL HOLLOW | FREELAND, MI
Now selling from the low $300s

One- and two-story floor plans Up to four bedrooms, 3 bathrooms and 2,014 square feet 2-bay attached garages Open-concept layouts with basements, owner's suites with walk-in closets and attached baths, main-floor bedrooms (select plans), great rooms, and upstairs laundry rooms Quartz countertops, LG® stainless-steel appliances, Kohler® fixtures, luxury vinyl plank flooring, and more included Convenient access to Saginaw, Bay City, and Midland Less than five miles to MBS International Airport Near Freeland SportsZone and Hayes Park Less than three miles from elementary, middle, and high schools in the well-rated Freeland Community School District Location:
Stone Briar Lane
Freeland, MI 48623
248.621.2895

VISIT OUR SALES STUDIO
While our state-of-the-art online homebuying process allows you to buy on your terms—24 hours a day, 7 days a week, 365 days a year—we also offer in-person assistance from local experts at our Sales Studio.

Brighton Studio
8373 W. Grand River Avenue
Brighton, MI 48116
248.621.2895

THE FREEDOM OF ONLINE HOMEBUYING

Century Complete is proud to feature its industry-first online homebuying experience on all available homes in Michigan, allowing homebuyers to easily find their best fit and purchase when they're ready—all while continuing to work with their local real estate agent of choice. Homebuyers can further streamline the homebuying process by financing online with Century Complete's affiliate lender, Inspire Home Loans®.

How it works:

Shop homes at CenturyCommunities.com Click "Buy Now" on any available home Fill out a quick Buy Online form Electronically submit an initial earnest money deposit Electronically sign a purchase contract via DocuSign® Learn more about the Buy Online experience at www.CenturyCommunities.com/online-homebuying.

About Century Communities
Century Communities, Inc. (NYSE: CCS) is one of the nation's largest homebuilders and a recognized industry leader in online home sales. Newsweek has named the Company one of America's Most Trustworthy Companies for four consecutive years. Century Communities has also been designated as one of U.S. News & World Report's Best Companies to Work For (2025–2026). Through its Century Communities and Century Complete brands, Century's mission is to build attractive, high-quality homes at affordable prices to provide its valued customers with A HOME FOR EVERY DREAM®. Century is engaged in all aspects of homebuilding — including the acquisition, entitlement and development of land, along with the construction, innovative marketing and sale of quality homes designed to appeal to a wide range of homebuyers. The Company operates in 16 states and over 45 markets across the U.S., and also offers mortgage, title, insurance brokerage, and escrow services in select markets through its Inspire Home Loans, Parkway Title, IHL Home Insurance Agency, and IHL Escrow subsidiaries. To learn more about Century Communities, please visit www.centurycommunities.com.

SOURCE Century Communities, Inc.
2026-06-12 14:19 2mo ago
2026-06-11 11:00 2mo ago
CCS Facility Services Accelerates National Growth with Entry into Ohio
CCS Century Communities
FMP Stock News
Original source text
DENVER--(BUSINESS WIRE)-- #K12--CCS Facility Services has expanded into Ohio, its fourteenth state, strengthening its Midwest presence.
2026-06-12 14:19 2mo ago
2026-06-11 15:45 2mo ago
Century Communities to Celebrate Grand Opening of Fulshear Junction, a New Walkable Community in Fulshear, Texas
CCS Century Communities
FMP Stock News
Original source text
June 13 event marks the debut of new single-family homes and community parks in a prime location with unique access to both Highway 359 and FM 1093

, /PRNewswire/ --

Key Takeaways:

Model Exterior | Fulshear Junction by Century Communities | New Construction Homes in Fulshear, TX

Model Kitchen | Fulshear Junction by Century Communities | Single-Family Homes in Fulshear, TX

Aerial Photo of Fulshear Junction | New Homes in Fulshear, TX by Century Communities Fulshear Junction to host Grand Opening event on June 13, officially welcoming homebuyers to the anticipated mixed-use community in Fulshear, Texas—the nation's second-fastest-growing city. Single-family homes with parks, in a walkable setting to nearby commercial and downtown Fulshear New homes now selling from the high $300s, with six floor plans and a model home available for tour Community offers unique access to both Highway 359 and FM 1093 Zoned to Lamar Consolidated Independent School District Century Communities, Inc. (NYSE: CCS)—a top national homebuilder, industry leader in online home sales, and featured on America's Most Trustworthy Companies by Newsweek—announced a Grand Opening event to be held on June 13 from 12 to 3 p.m. for Fulshear Junction, officially opening the doors to the anticipated single-family home community in Fulshear, Texas, the nation's second-fastest-growing city.

The celebratory event will feature tours of Fulshear Junction's new model home—showcasing the two-story Savannah floor plan—a look at available homes under construction, ready for move-in this summer, and special Grand Opening savings opportunities. Attendees will also have the opportunity to explore neighborhood parks, playgrounds, and preserved green spaces.

Learn more, explore available homes, and RSVP for the Grand Opening at www.CenturyCommunities.com/FulshearJunctionGO.

"Fulshear Junction represents the next chapter of growth for this thriving area, bringing to life a thoughtfully connected setting where new homes, commercial opportunities, and natural spaces come together. It's also just down the road from our other exceptional communities in this fast-growing area: Fulshear Lakes in Fulshear and Laurel Farms in Brookshire," said Tanya Rizzo, Division President for Century Communities in Houston. "With Fulshear Junction, we're proud to deliver a community that balances natural surroundings, preserved tree lines, and multiple parks with convenient access to key corridors like Highway 359 and FM 1093."

Community Highlights:

New single-family homes in a growing west Houston location Walkable community with parks, green space, and future on-site commercial offerings Parks, playground, walking paths, and preserved tree lines Convenient access to Highway 359 and FM 1093 Served by Lamar Consolidated Independent School District Home Features:

Six thoughtfully designed floor plans Up to five bedrooms and up to 3.5 bathrooms Two-bay garages Front porch living Move-in package, upgraded tile, smart home package and more included Model home for tour (Savannah plan) Pricing from the high $300s Sales Office:
8427 Monorail Drive
Fulshear, TX 77441
281.698.1160

THE FREEDOM OF ONLINE HOMEBUYING:
Century Communities is proud to feature its industry-first online homebuying experience on all available homes in Houston.

How it works:

Shop homes at CenturyCommunities.com Click "Buy Now" on any available home Fill out a quick Buy Online form Electronically submit an initial earnest money deposit Electronically sign a purchase contract via DocuSign® Learn more about the Buy Online experience at www.CenturyCommunities.com/online-homebuying.

About Century Communities
Century Communities, Inc. (NYSE: CCS) is one of the nation's largest homebuilders and a recognized industry leader in online home sales. Newsweek has named the Company one of America's Most Trustworthy Companies for four consecutive years. Century Communities has also been designated as one of U.S. News & World Report's Best Companies to Work For (2025–2026). Through its Century Communities and Century Complete brands, Century's mission is to build attractive, high-quality homes at affordable prices to provide its valued customers with A HOME FOR EVERY DREAM®. Century is engaged in all aspects of homebuilding — including the acquisition, entitlement and development of land, along with the construction, innovative marketing and sale of quality homes designed to appeal to a wide range of homebuyers. The Company operates in 16 states and over 45 markets across the U.S., and also offers mortgage, title, insurance brokerage, and escrow services in select markets through its Inspire Home Loans, Parkway Title, IHL Home Insurance Agency, and IHL Escrow subsidiaries. To learn more about Century Communities, please visit www.centurycommunities.com.

SOURCE Century Communities, Inc.
2026-06-12 14:19 2mo ago
2026-05-07 10:40 4mo ago
Here's Why AMN Healthcare Services (AMN) is a Strong Value Stock
AMN AMN Healthcare Services
FMP Stock News
Original source text
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.

It also includes access to the Zacks Style Scores.

What are the Zacks Style Scores? The Zacks Style Scores, developed alongside the Zacks Rank, are complementary indicators that rate stocks based on three widely-followed investing methodologies; they also help investors pick stocks with the best chances of beating the market over the next 30 days.

Each stock is assigned a rating of A, B, C, D, or F based on their value, growth, and momentum characteristics. Just like in school, an A is better than a B, a B is better than a C, and so on -- that means the better the score, the better chance the stock will outperform.

The Style Scores are broken down into four categories:

Value ScoreFor value investors, it's all about finding good stocks at good prices, and discovering which companies are trading under their true value before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to help pick out the most attractive and discounted stocks.

Growth ScoreGrowth investors, on the other hand, are more concerned with a company's financial strength and health, and its future outlook. The Growth Style Score examines things like projected and historic earnings, sales, and cash flow to find stocks that will experience sustainable growth over time.

Momentum ScoreMomentum trading is all about taking advantage of upward or downward trends in a stock's price or earnings outlook, and these investors live by the saying "the trend is your friend." The Momentum Style Score can pinpoint good times to build a position in a stock, using factors like one-week price change and the monthly percentage change in earnings estimates.

VGM ScoreIf you like to use all three kinds of investing, then the VGM Score is for you. It's a combination of all Style Scores, and is an important indicator to use with the Zacks Rank. The VGM Score rates each stock on their shared weighted styles, narrowing down the companies with the most attractive value, best growth forecast, and most promising momentum.

How Style Scores Work with the Zacks Rank The Zacks Rank, which is a proprietary stock-rating model, employs earnings estimate revisions, or changes to a company's earnings expectations, to make building a winning portfolio easier.

Investors can count on the Zacks Rank's success, with #1 (Strong Buy) stocks producing an unmatched +23.93% average annual return since 1988, more than double the S&P 500's performance. But the model rates a large number of stocks, and there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.

But it can feel overwhelming to pick the right stocks for you and your investing goals with over 800 top-rated stocks to choose from.

That's where the Style Scores come in.

You want to make sure you're buying stocks with the highest likelihood of success, and to do that, you'll need to pick stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you like a stock that only has a #3 (Hold) rank, it should also have Scores of A or B to guarantee as much upside potential as possible.

As mentioned above, the Scores are designed to work with the Zacks Rank, so any change to a company's earnings outlook should be a deciding factor when picking which stocks to buy.

For instance, a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one that boasts Scores of A and B, still has a downward-trending earnings forecast, and a much greater likelihood its share price will decline as well.

Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.

Stock to Watch: AMN Healthcare Services (AMN - Free Report) AMN Healthcare Services, Inc. (AMN - Free Report) , operating from Dallas, TX, is a travel healthcare staffing company. Its business has evolved beyond traditional healthcare staffing and recruitment services, thereby becoming a strategic total talent solutions partner with its clients. It has expanded its portfolio to serve a diverse and growing set of healthcare talent-related needs. In addition to its healthcare professional staffing and recruitment services, AMN’s suite of healthcare workforce solutions includes MSP, vendor management systems (VMS), medical language interpretation services, predictive labor analytics, workforce optimization technology and consulting, recruitment process outsourcing (RPO), revenue cycle solutions, credentialing services and virtual care management services. AMN enables its clients to build, manage and optimize their healthcare talent to deliver improved patient outcomes and experience. It continues to enhance its platform with technology-enabled solutions, including digital workforce platforms, automation tools and AI-driven capabilities to improve speed, efficiency and clinician engagement.

AMN is a #2 (Buy) on the Zacks Rank, with a VGM Score of A.

It also boasts a Value Style Score of A thanks to attractive valuation metrics like a forward P/E ratio of 10.88; value investors should take notice.

One analyst revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $0.47 to $1.93 per share. AMN boasts an average earnings surprise of +79.6%.

With a solid Zacks Rank and top-tier Value and VGM Style Scores, AMN should be on investors' short list.
2026-06-12 14:19 2mo ago
2026-05-07 16:15 4mo ago
AMN Healthcare Announces First Quarter 2026 Results
AMN AMN Healthcare Services
FMP Stock News
Original source text
Quarterly revenue of $1.378 billion and adjusted EBITDA of $166 million;
GAAP income of $1.59/share and adjusted EPS of $2.10

DALLAS, May 07, 2026 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its first quarter 2026 financial results. Financial highlights are as follows:

Dollars in millions, except per share amounts.

 Q1 2026% Change Q1 2025Revenue$1,378.4100%Gross profit$368.886%Net income$62.2nmGAAP diluted EPS$1.59nmAdjusted diluted EPS*$2.10366%Adjusted EBITDA*$166.1159%    * See “Non-GAAP Measures” below for a discussion of our use of non-GAAP items and the table entitled “Non-GAAP Reconciliation Tables” for a reconciliation of non-GAAP items.

Business Highlights

First quarter revenue and earnings exceeded guidance with labor disruption, travel nurse, allied, and international nurse exceeding expectations.Travel nursing volume and revenue grew year over year for the first time since 2022.Allied, schools, international nurse, and search also delivered year-over-year revenue growth.Cash flow from operations of $562 million and our quarter-end cash balance of $561 million benefited from favorable timing of working capital related to recent labor disruption events.We ended the quarter with $750 million of debt, an undrawn revolving credit facility and a leverage ratio, calculated under the terms of our credit agreement, of 1.6x. “Our first quarter performance demonstrated strong execution across AMN, with results exceeding our expectations and guidance while navigating a dynamic market environment,” said Cary Grace, President and Chief Executive Officer of AMN Healthcare. “We delivered solid underlying growth in Nurse and Allied Solutions, saw momentum return in international staffing and search, and continued to advance our technology-enabled workforce solutions. The AMN team did an outstanding job supporting our clients and healthcare professionals, demonstrating the power of our enhanced technology platform and solutions to deliver at our highest level since the pandemic.”

First Quarter 2026 Results

Consolidated revenue for the quarter was $1.378 billion, a 100% increase from prior year and an 84% increase from the prior quarter. Net income was $62 million (4.5% of revenue), or $1.59 per diluted share, compared with net loss of $1 million (0.2% of revenue), or ($0.03) per diluted share in the first quarter of 2025. Adjusted diluted EPS in the first quarter was $2.10 compared with $0.45 in the same quarter a year ago.

Revenue for the Nurse and Allied Solutions segment was $1.127 billion, higher by 173% year over year and up 130% from the prior quarter. Travel nurse staffing revenue was higher by 12% year over year and 16% sequentially. Allied division revenue increased 3% year over year and sequentially. Labor disruption events contributed $722 million revenue in the quarter.

The Physician and Leadership Solutions segment reported revenue of $164 million, down 6% year over year and 3% lower sequentially. Locum tenens revenue was $131 million, down 7% year over year and 4% sequentially. Interim leadership revenue was down by 4% year over year and 5% lower sequentially. Our search businesses saw revenue increase by 4% both year over year and sequentially.

Technology and Workforce Solutions segment revenue was $87 million, a decrease of 15% year over year and 1% sequentially. Language services revenue was $69 million in the quarter, down 8% from the prior year and down 1% sequentially. Vendor management systems revenue was $16 million, 18% lower year over year and down 2% from the prior quarter.

Consolidated gross margin was 26.8%, 190 basis points lower year over year and up 70 basis points sequentially. Higher margins in the Nurse and Allied Solutions and Technology and Workforce Solutions segments drove the sequential improvement.

Consolidated SG&A expenses were $218 million, or 15.8% of revenue, compared with $148 million, or 21.4% of revenue, in the same quarter last year. SG&A was $152 million, or 20.3% of revenue, in the previous quarter. The year-over-year increase in SG&A costs was driven primarily by expenses related to the large labor disruption events in the quarter.

Income from operations was $117 million with an operating margin of 8.5%, compared with income of $13 million and 1.8%, respectively, in the same quarter last year. Adjusted EBITDA was $166 million, a year-over-year increase of 159%. Adjusted EBITDA margin was 12.1%, 280 basis points higher than the year-ago period.

At March 31, 2026, cash and cash equivalents totaled $561 million. Cash flow from operations was $562 million for the first quarter. The cash balance and cash flow benefited from favorable timing of working capital related to labor disruption events resulting in $367 million of client deposits at quarter end that will be settled in the coming months. Capital expenditures were $7 million. The Company ended the quarter with total debt outstanding of $750 million with nothing drawn on our revolving credit facility.

Second Quarter 2026 Outlook

MetricGuidance*Consolidated revenue$620 - $635 millionGross margin28.0% - 28.5%SG&A as percentage of revenue23.0% - 23.5%Operating margin(0.6%) - 0.1%Adjusted EBITDA margin6.7% - 7.2% *Note: Guidance percentage metrics are approximate.   For a reconciliation of adjusted EBITDA margin, see the table entitled “Reconciliation of Guidance Operating Margin to Guidance Adjusted EBITDA Margin” below.

Revenue in the second quarter of 2026 is expected to be 4-6% lower than the prior year, or down 3-5% excluding labor disruption revenue of approximately $10 million this quarter compared with $16 million in the second quarter of 2025. Nurse and Allied Solutions segment revenue is expected to be down 0-2% year over year. Physician and Leadership Solutions segment revenue is expected to be down 6-8% year over year. Technology and Workforce Solutions segment revenue is projected to be down 14-16% year over year, including a (4%) effect from the divestiture of Smart Square at the beginning of third quarter 2025.

Second quarter estimates for certain other financial items include depreciation of $15 million, depreciation in cost of revenue of $2.5 million, non-cash amortization expense of $18 million, share-based compensation expense of $7 million, integration and other expenses of $3 million, interest expense of $8 million, marginal adjusted tax rate of 28%, and 39.3 million diluted average shares outstanding.

Conference Call on May 7, 2026

AMN Healthcare Services, Inc. (NYSE: AMN) will host a conference call to discuss its first quarter 2026 financial results and second quarter 2026 outlook on Thursday, May 7, 2026 at 5:00 p.m. Eastern Time. A live webcast of the call can be accessed through AMN Healthcare’s website at http://ir.amnhealthcare.com. Interested parties may participate live via telephone by registering at this link. Registrants will receive confirmation and dial-in details. Following the conclusion of the call, a replay of the webcast will be available at the Company’s investor relations website.

About AMN Healthcare

AMN Healthcare is the leader and innovator in total talent solutions for healthcare organizations across the United States. The Company provides access to the most comprehensive network of quality healthcare professionals through its innovative recruitment strategies and breadth of career opportunities. With insights and expertise, AMN Healthcare helps providers optimize their workforce to successfully reduce complexity, increase efficiency and improve patient outcomes. AMN total talent solutions include managed services programs, clinical and interim healthcare leaders, temporary staffing, direct hire and retained search solutions, vendor management systems, recruitment process outsourcing, predictive modeling, language interpretation services, revenue cycle solutions, credentialing, and other services. Clients include acute-care hospitals, community health centers and clinics, physician practice groups, retail and urgent care centers, home health facilities, schools, and many other healthcare settings. AMN Healthcare is committed to fostering and maintaining a diverse team that reflects the communities we serve. Our commitment to the inclusion of many different backgrounds, experiences and perspectives enables our innovation and leadership in the healthcare services industry.
The Company’s common stock is listed on the New York Stock Exchange under the symbol “AMN.” For more information about AMN Healthcare, visit www.amnhealthcare.com, where the Company posts news releases, investor presentations, webcasts, SEC filings and other material information. The Company also utilizes email alerts and Really Simple Syndication (“RSS”) as routine channels to supplement distribution of this information. To register for email alerts and RSS, visit http://ir.amnhealthcare.com.

Non-GAAP Measures

This earnings release and the non-GAAP reconciliation tables included with the earnings release contain certain non-GAAP financial information, which the Company provides as additional information, and not as an alternative, to the Company’s condensed consolidated financial statements presented in accordance with GAAP. These non-GAAP financial measures include (1) adjusted EBITDA, (2) adjusted EBITDA margin, (3) adjusted net income, and (4) adjusted diluted EPS. The Company provides such non-GAAP financial measures because management believes that they are useful to both management and investors as a supplement, and not as a substitute, when evaluating the Company’s operating performance. Additionally, management believes that adjusted EBITDA, adjusted EBITDA margin, and adjusted diluted EPS serve as industry-wide financial measures. The Company uses adjusted EBITDA for making financial decisions, allocating resources and for determining certain incentive compensation objectives. The non-GAAP measures in this release are not in accordance with, or an alternative to, GAAP measures and may be different from non-GAAP measures, or may be calculated differently than other similarly titled non-GAAP measures, reported by other companies. They should not be used in isolation to evaluate the Company’s performance. A reconciliation of non-GAAP measures identified in this release, along with further detail about the use and limitations of certain of these non-GAAP measures, may be found below in the table entitled “Non-GAAP Reconciliation Tables” under the caption entitled “Reconciliation of Non-GAAP Items” and the footnotes thereto or on the Company’s website at https://ir.amnhealthcare.com/financials/quarterly-results. Additionally, from time to time, additional information regarding non-GAAP financial measures, including pro forma measures, may be made available on the Company’s website.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, among others, statements concerning future demand and supply for healthcare, contingent staffing and other services, client preferences, momentum in international staffing and search, our ability to advance our technology-enabled workforce solutions, settlement of client deposits, second quarter 2026 financial projections for consolidated and segment revenue, consolidated gross margin, operating margin, SG&A as a percent of revenue, adjusted EBITDA margin, labor disruption revenue, depreciation expense, depreciation in cost of revenue, share-based compensation expense, non-cash amortization expense, integration and other expenses, interest expense, adjusted tax rate, and number of diluted shares outstanding. The Company bases these forward-looking statements on its current expectations, estimates and projections about future events and the industry in which it operates using information currently available to it. Actual results could differ materially from those discussed in, or implied by, these forward-looking statements. Forward-looking statements are also identified by words such as “believe,” "project," “anticipate,” “expect,” “intend,” “plan,” “will,” “may,” “estimates,” variations of such words and other similar expressions. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements.

The targets and expectations noted in this release depend upon, among other factors, (i) the ability of our clients to increase the efficiency and effectiveness of their staffing management and recruiting efforts, through predictive analytics, online recruiting, internal travel agencies and float pools, telemedicine or otherwise and successfully hire and retain permanent staff, (ii) the duration and extent to which hospitals and other healthcare entities adjust their utilization of temporary nurses and allied healthcare professionals, physicians, healthcare leaders and other healthcare professionals and workforce technology applications as a result of the labor market or economic conditions, (iii) the magnitude and duration of the effects of the post-COVID-19 pandemic environment or any future pandemic or health crisis on demand and supply trends, our business, its financial condition and our results of operations, (iv) our ability to effectively address client demand by attracting and placing nurses and other clinicians, (v) our ability to recruit and retain sufficient quality healthcare professionals at reasonable costs, (vi) our ability to anticipate and quickly respond to changing marketplace conditions, such as alternative modes of healthcare delivery, reimbursement, or client needs and requirements, including implementing changes that will make our services more tech-enabled and integrated, (vii) our ability to manage the pricing impact that the labor market or consolidation of healthcare delivery organizations may have on our business, (viii) the effects of economic downturns, inflation or slow recoveries, which could result in less demand for our services, increased client initiatives designed to contain costs, including reevaluating their approach as it pertains to contingent labor and managed services programs, other solutions and providers, pricing pressures and negatively impact payments terms and collectability of accounts receivable, (ix) our ability to develop and evolve our current technology offerings and capabilities and implement new infrastructure and technology systems to optimize our operating results and manage our business effectively, (x) our ability and the expense to comply with extensive and complex federal and state laws and regulations related to the conduct of our operations, costs and payment for services and payment for referrals as well as laws regarding employment practices, (xi) our ability to consummate and effectively incorporate acquisitions into our business, (xii) the negative effects that intermediary organizations may have on our ability to secure new and profitable contracts, (xiii) the extent to which the Great Resignation or a future spike in the COVID-19 pandemic or other pandemic or health crisis may disrupt our operations due to the unavailability of our employees or healthcare professionals due to burnout, illness, risk of illness, quarantines, travel restrictions, mandatory vaccination requirements, or other factors that limit our existing or potential workforce and pool of candidates, (xiv) security breaches and cybersecurity incidents, including ransomware, that could compromise our information and systems, which could adversely affect our business operations and reputation and could subject us to substantial liabilities and (xv) the severity and duration of the impact the labor market, economic downturn or any future pandemic or health crisis has on the financial condition and cash flow of many hospitals and healthcare systems such that it impairs their ability to make payments to us, timely or otherwise, for services rendered.

For a discussion of additional risk factors and a more complete discussion of some of the cautionary statements noted above that could cause actual results to differ from those implied by the forward-looking statements contained in this press release, please refer to our most recent Annual Report on Form 10-K for the year ended December 31, 2025. Be advised that developments subsequent to this press release are likely to cause these statements to become outdated and the Company is under no obligation (and expressly disclaims any such obligation) to update or revise any forward-looking statements whether as a result of new information, future events, or otherwise.

Contact:
Randle Reece
Vice President, Investor Relations & Strategy
866.861.3229

  AMN Healthcare Services, Inc.
Condensed Consolidated Statements of Comprehensive Income (Loss)
(in thousands, except per share amounts)
(unaudited)
   Three Months Ended March 31, December 31, 2026 2025 2025Revenue$1,378,361  $689,533  $748,225 Cost of revenue 1,009,525   491,413   553,098 Gross profit 368,836   198,120   195,127 Gross margin 26.8%  28.7%  26.1%Operating expenses:     Selling, general and administrative (SG&A) 218,425   147,731   152,113 SG&A as a % of revenue 15.8%  21.4%  20.3%      Depreciation and amortization (exclusive of depreciation included in cost of revenue) 33,240   37,882   34,854 Loss on sale of disposal group —   —   42 Total operating expenses 251,665   185,613   187,009 Income from operations 117,171   12,507   8,118 Operating margin (1) 8.5%  1.8%  1.1%      Interest expense, net, and other 6,712   12,324   12,280       Income (loss) before income taxes 110,459   183   (4,162)      Income tax expense 48,293   1,275   3,534 Net income (loss)$62,166  $(1,092) $(7,696)Net income (loss) as a % of revenue 4.5% (0.2)% (1.0)%      Other comprehensive income (loss):     Unrealized gains (losses) on available-for-sale securities, net, and other (185)  61   (286)Other comprehensive income (loss) (185)  61   (286)      Comprehensive income (loss)$61,981  $(1,031) $(7,982)      Net income (loss) per common share:     Basic$1.60  $(0.03) $(0.20)Diluted$1.59  $(0.03) $(0.20)Weighted average common shares outstanding:     Basic 38,902   38,312   38,733 Diluted 39,118   38,312   38,733        AMN Healthcare Services, Inc.
Condensed Consolidated Balance Sheets
(dollars in thousands)
(unaudited)
          March 31, 2026
 December 31, 2025
 March 31, 2025
Assets        Current assets:        Cash and cash equivalents$560,738  $33,972  $55,777 Accounts receivable, net 394,668   382,560   421,869 Accounts receivable, subcontractor 47,501   48,041   65,307 Prepaid and other current assets 133,613   80,803   84,404 Total current assets 1,136,520   545,376   627,357 Restricted cash, cash equivalents and investments 45,814   45,606   45,070 Fixed assets, net 126,029   136,361   177,996 Other assets 263,408   282,552   253,670 Deferred income taxes, net 11,212   44,877   31,637 Goodwill 755,809   755,809   897,456 Intangible assets, net 265,581   283,526   361,937 Total assets$2,604,373  $2,094,107  $2,395,123          Liabilities and stockholders’ equity        Current liabilities:        Accounts payable and accrued expenses$197,385  $161,968  $195,974 Accrued compensation and benefits 317,137   298,837   269,497 Other current liabilities 529,668   116,809   116,778 Total current liabilities 1,044,190   577,614   582,249 Revolving credit facility —   25,000   150,000 Notes payable, net 742,491   742,053   846,167 Other long-term liabilities 104,886   107,334   101,656 Total liabilities 1,891,567   1,452,001   1,680,072          Commitments and contingencies                 Stockholders’ equity: 712,806   642,106   715,051          Total liabilities and stockholders’ equity$2,604,373  $2,094,107  $2,395,123           AMN Healthcare Services, Inc.
Summary Condensed Consolidated Statements of Cash Flows
(dollars in thousands)
(unaudited)
   Three Months Ended March 31, December 31, 2026 2025 2025      Net cash provided by operating activities$562,452  $92,671  $75,572 Net cash used in investing activities (7,504)  (26,046)  (8,053)Net cash used in financing activities (27,135)  (61,211)  (83,242)Net increase (decrease) in cash, cash equivalents and restricted cash 527,813   5,414   (15,723)Cash, cash equivalents and restricted cash at beginning of period 67,171   89,305   82,894 Cash, cash equivalents and restricted cash at end of period$594,984  $94,719  $67,171              AMN Healthcare Services, Inc.
Non-GAAP Reconciliation Tables
(dollars in thousands, except per share data)
(unaudited)
   Three Months Ended March 31, December 31, 2026 2025 2025Reconciliation of Non-GAAP Items:           Net income (loss)$62,166  $(1,092) $(7,696)Income tax expense 48,293   1,275   3,534 Income (loss) before income taxes 110,459   183   (4,162)Interest expense, net, and other 6,712   12,324   12,280 Income from operations 117,171   12,507   8,118 Depreciation and amortization 33,240   37,882   34,854 Depreciation (included in cost of revenue) (2) 2,420   1,975   2,376 Loss on sale of disposal group —   —   42 Share-based compensation 9,892   9,381   5,762 Acquisition, integration, and other costs (3) 3,402   2,455   3,331 Adjusted EBITDA (4)$166,125  $64,200  $54,483       Adjusted EBITDA margin (5) 12.1%  9.3%  7.3%      Net income (loss)$62,166  $(1,092) $(7,696)Adjustments:     Amortization of intangible assets 17,945   19,427   18,551 Acquisition, integration, and other costs (3) 3,402   2,455   3,331 Loss on sale of disposal group —   —   42 Debt financing related costs —   —   1,156 Tax effect on above adjustments (5,550)  (5,689)  (6,001)Tax effect of COLI fair value changes (6) 2,065   703   (1,713)Tax deficiencies (benefits) related to equity awards and ESPP (7) 2,151   1,523   892 Adjusted net income (8)$82,179  $17,327  $8,562       GAAP diluted net income (loss) per share (EPS)$1.59  $(0.03) $(0.20)Adjustments 0.51   0.48   0.42 Adjusted diluted EPS (9) (10)$2.10  $0.45  $0.22              AMN Healthcare Services, Inc.
Supplemental Segment Financial and Operating Data
(dollars in thousands, except operating data)
(unaudited)
   Three Months Ended March 31, December 31, 2026 2025 2025Revenue     Nurse and allied solutions$1,127,342  $413,261  $490,710 Physician and leadership solutions 163,924   174,065   169,552 Technology and workforce solutions 87,095   102,207   87,963  $1,378,361  $689,533  $748,225       Segment operating income (11)     Nurse and allied solutions$153,330  $32,238  $36,484 Physician and leadership solutions 10,818   14,462   12,918 Technology and workforce solutions 25,270   35,250   24,896   189,418   81,950   74,298 Unallocated corporate overhead (12) 23,293   17,750   19,815 Adjusted EBITDA (4)$166,125  $64,200  $54,483       Gross Margin     Nurse and allied solutions 25.1%  22.7%  21.6%Physician and leadership solutions 26.1%  27.3%  27.5%Technology and workforce solutions 50.0%  55.5%  48.1%            Operating Data:     Nurse and allied solutions     Average travelers on assignment (13) 9,227   8,981   8,722       Physician and leadership solutions     Days filled (14) 46,645   51,342   48,004 Revenue per day filled (15)$2,812  $2,743  $2,834         As of March 31, As of December 31, 2026 2025 2025Leverage ratio (16)1.6 3.1 3.3       AMN Healthcare Services, Inc.
Additional Supplemental Non-GAAP Disclosure
Reconciliation of Guidance Operating Margin to Guidance
Adjusted EBITDA Margin
(unaudited)
   Three Months Ended June 30, 2026 Low(17) High(17)    Operating margin(0.6)% 0.1%Depreciation and amortization (total)5.7% 5.5%EBITDA margin5.1% 5.6%Share-based compensation1.1% 1.1%Integration and other costs0.5% 0.5%Adjusted EBITDA margin6.7% 7.2% (1)Operating margin represents income from operations divided by revenue.(2)A portion of depreciation expense for AMN Language Services is included in cost of revenue. We exclude the impact of depreciation included in cost of revenue from the calculation of adjusted EBITDA.(3)Acquisition, integration, and other costs include acquisition and integration costs, net changes in the fair value of contingent consideration liabilities for recently acquired companies, certain legal expenses, restructuring expenses and other costs associated with exit or disposal activities, and certain nonrecurring expenses, which we exclude from the calculation of adjusted EBITDA, adjusted net income, and adjusted diluted EPS because we believe that these expenses are not indicative of the Company’s operating performance. For the three months ended March 31, 2026, acquisition and integration costs were approximately $0.9 million, certain legal expenses were approximately $1.0 million, restructuring expenses and other costs associated with exit or disposal activities were approximately $0.6 million, and other nonrecurring expenses were approximately $0.9 million. For the three months ended March 31, 2025, acquisition and integration costs were approximately $0.3 million, expenses related to the closures of certain office leases were approximately $0.2 million, certain legal expenses were approximately $1.1 million, restructuring expenses and other costs associated with exit or disposal activities were approximately $0.4 million, and other nonrecurring expenses were approximately $0.4 million. For the three months ended December 31, 2025, acquisition and integration costs were approximately $0.5 million, certain legal expenses were approximately $0.8 million, expenses related to the closures of certain office leases were approximately $0.2 million, restructuring expenses and other costs associated with exit or disposal activities were approximately $0.8 million, and other expenses were approximately $1.0 million.(4)Adjusted EBITDA represents net income (loss) plus interest expense (net of interest income) and other, income tax expense, depreciation and amortization, depreciation (included in cost of revenue), loss on sale of disposal group, share-based compensation, acquisition, integration, and other costs, restructuring expenses, and certain legal expenses. Management believes that adjusted EBITDA provides an effective measure of the Company’s results, as it excludes certain items that management believes are not indicative of the Company’s operating performance. Adjusted EBITDA is not intended to represent cash flows for the period, nor has it been presented as an alternative to income from operations or net income (loss) as an indicator of operating performance. Although management believes that some of the items excluded from adjusted EBITDA are not indicative of the Company’s operating performance, these items do impact the statement of comprehensive income (loss), and management therefore utilizes adjusted EBITDA as an operating performance measure in conjunction with GAAP measures such as net income (loss).(5)Adjusted EBITDA margin represents adjusted EBITDA divided by revenue.(6)The Company records net tax expense (benefit) related to the income tax treatment of the fair value changes in the cash surrender value of its company owned life insurance (“COLI”). Since this change in fair value is unrelated to the Company’s operating performance, we excluded the impact on adjusted net income and adjusted diluted EPS.(7)The consolidated effective tax rate is affected by the recording of tax benefits and tax deficiencies related to equity awards vested during the period and tax benefits recognized for disqualifying dispositions related to our employee stock purchase plan (“ESPP”). The magnitude of the impact of tax benefits and tax deficiencies generated in the future related to equity awards and ESPP is dependent upon the Company’s future grants of share-based compensation, the Company’s future stock price on the date equity awards vest in relation to the fair value of the awards on the grant date, the Company’s future stock price on either the ESPP’s offering date or purchase date, whichever is lower, and the length of time the shares issued under the ESPP are held by employees. Since these tax benefits and tax deficiencies related to equity awards and ESPP are largely unrelated to our income (loss) before income taxes and are unrepresentative of our normal effective tax rate, we excluded their impact in the calculation of adjusted net income and adjusted diluted EPS.(8)Adjusted net income represents GAAP net income (loss) excluding the impact of the (A) amortization of intangible assets, (B) acquisition, integration, and other costs, (C) loss on sale of disposal group, (D) deferred financing related costs, (E) tax effect, if any, of the foregoing adjustments, (F) net tax expense (benefit) related to the income tax treatment of fair value changes in the cash surrender value of its COLI and (G) tax deficiencies and tax benefits related to equity awards vested and ESPP. Management included this non-GAAP measure to provide investors and prospective investors with an alternative method for assessing the Company’s operating results in a manner that is focused on its operating performance and to provide a more consistent basis for comparison between periods. However, investors and prospective investors should note that this non-GAAP measure involves judgment by management (in particular, judgment as to what is classified as a special item to be excluded in the calculation of adjusted net income). Although management believes the items in the calculation of adjusted net income are not indicative of the Company’s operating performance, these items do impact the statement of comprehensive income (loss), and management therefore utilizes adjusted net income as an operating performance measure in conjunction with GAAP measures such as GAAP net income (loss).(9)Adjusted diluted EPS represents adjusted net income divided by diluted weighted average common shares outstanding. Management included this non-GAAP measure to provide investors and prospective investors with an alternative method for assessing the Company’s operating results in a manner that is focused on its operating performance and to provide a more consistent basis for comparison between periods. However, investors and prospective investors should note that this non-GAAP measure involves judgment by management (in particular, judgment as to what is classified as a special item to be excluded in the calculation of adjusted net income). Although management believes the items in the calculation of adjusted net income are not indicative of the Company’s operating performance, these items do impact the statement of comprehensive income (loss), and management therefore utilizes adjusted diluted EPS as an operating performance measure in conjunction with GAAP measures such as GAAP diluted EPS.(10)As GAAP net loss is reported for the three months ended March 31, 2025 and December 31, 2025, basic weighted average common shares outstanding was used to calculate GAAP diluted EPS for those periods because the dilutive potential common shares have an anti-dilutive effect (i.e., result in a lower loss per share). As adjusted net income is reported for the three months ended March 31, 2025 and December 31, 2025, diluted weighted average common shares outstanding (including dilutive potential common shares) of 38,414 and 38,817, respectively, were used to calculate adjusted diluted EPS.(11)Segment operating income represents net income (loss) plus interest expense (net of interest income) and other, income tax expense (benefit), depreciation and amortization, depreciation (included in cost of revenue), unallocated corporate overhead, acquisition, integration, and other costs, legal settlement accrual changes, share-based compensation, and loss on sale of disposal group.(12)Unallocated corporate overhead (as presented in the tables above) consists of unallocated corporate overhead (as reflected in our quarterly and annual financial statements filed with the SEC) less acquisition, integration, and other costs and legal settlement accrual changes.(13)Average travelers on assignment represents the average number of nurse and allied healthcare professionals on assignment during the period presented.(14)Days filled is calculated by dividing the locum tenens hours filled during the period by eight hours.(15)Revenue per day filled represents revenue of the Company’s locum tenens business divided by days filled for the period presented.(16)Leverage ratio represents the ratio of the consolidated funded indebtedness (as calculated per the Company’s credit agreement) at the end of the subject period to the consolidated adjusted EBITDA (as calculated per the Company’s credit agreement) for the twelve-month period ended at the end of the subject period.(17)Guidance percentage metrics are approximate.
  
2026-06-12 14:19 2mo ago
2026-05-07 21:30 4mo ago
AMN Healthcare (AMN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
AMN AMN Healthcare Services
FMP Stock News
Original source text
AMN Healthcare Services (AMN - Free Report) reported $1.38 billion in revenue for the quarter ended March 2026, representing a year-over-year increase of 99.9%. EPS of $2.10 for the same period compares to $0.45 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $1.23 billion, representing a surprise of +11.9%. The company delivered an EPS surprise of +30.98%, with the consensus EPS estimate being $1.60.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how AMN Healthcare performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Revenue- Physician and leadership solutions: $163.92 million versus $163.01 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -5.8% change.Revenue- Nurse and allied solutions: $1.13 billion versus $984.24 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +172.8% change.Revenue- Technology and workforce solutions: $87.1 million compared to the $84.69 million average estimate based on two analysts. The reported number represents a change of -14.8% year over year.Segment operating income- Nurse and allied solutions: $153.33 million compared to the $97.77 million average estimate based on two analysts.Segment operating income- Technology and workforce solutions: $25.27 million versus $25.71 million estimated by two analysts on average.Segment operating income- Physician and leadership solutions: $10.82 million versus $13.62 million estimated by two analysts on average.View all Key Company Metrics for AMN Healthcare here>>>

Shares of AMN Healthcare have returned +10.5% over the past month versus the Zacks S&P 500 composite's +11.4% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.
2026-06-12 14:19 2mo ago
2026-05-07 23:26 4mo ago
AMN Healthcare Services (AMN) Tops Q1 Earnings and Revenue Estimates
AMN AMN Healthcare Services
FMP Stock News
Original source text
AMN Healthcare Services (AMN - Free Report) came out with quarterly earnings of $2.1 per share, beating the Zacks Consensus Estimate of $1.6 per share. This compares to earnings of $0.45 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +30.98%. A quarter ago, it was expected that this health care staffing company would post earnings of $0.22 per share when it actually produced earnings of $0.22, delivering no surprise.

Over the last four quarters, the company has surpassed consensus EPS estimates three times.

AMN Healthcare, which belongs to the Zacks Business - Services industry, posted revenues of $1.38 billion for the quarter ended March 2026, surpassing the Zacks Consensus Estimate by 11.90%. This compares to year-ago revenues of $689.53 million. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

AMN Healthcare shares have added about 33.1% since the beginning of the year versus the S&P 500's gain of 7.6%.

What's Next for AMN Healthcare?While AMN Healthcare has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for AMN Healthcare was favorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #2 (Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.10 on $627.69 million in revenues for the coming quarter and $1.93 on $3.14 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Business - Services is currently in the top 32% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Priority Technology (PRTH - Free Report) , another stock in the broader Zacks Business Services sector, has yet to report results for the quarter ended March 2026. The results are expected to be released on May 11.

This company is expected to post quarterly earnings of $0.22 per share in its upcoming report, which represents no change from the year-ago quarter. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Priority Technology's revenues are expected to be $240.35 million, up 7% from the year-ago quarter.
2026-06-12 14:18 2mo ago
2026-05-08 07:01 4mo ago
Best Value Stocks to Buy for May 8th
AMN AMN Healthcare Services
FMP Stock News
Original source text
Here are three stocks with buy rank and strong value characteristics for investors to consider today, May 8th:  

Atlanticus (ATLC - Free Report) : This company, which provides credit and related financial services and products, carries a Zacks Rank #1 (Strong Buy), and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.9% over the last 60 days.

Atlanticus has a price-to-earnings ratio (P/E) of 9.18 compared with 15.70 for the industry. The company possesses a Value Score of A.

DaVita (DVA - Free Report) : This company, which is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD), carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.8% over the last 60 days.

DaVita has a price-to-earnings ratio (P/E) of 13.59 compared with 27.40 for the industry. The company possesses a Value Score of A.

AMN Healthcare Services (AMN - Free Report) : This travel healthcare staffing company, which has expanded its portfolio to serve a diverse and growing set of healthcare talent-related needs, carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 32.2% over the last 60 days.

AMN Healthcare Services’ has a price-to-earnings ratio (P/E) of 10.88 compared with 17.20 for the industry. The company possesses a Value Score of A.

See the full list of top ranked stocks here.

Learn more about the Value score and how it is calculated here.
2026-06-12 14:18 2mo ago
2026-05-08 10:40 4mo ago
Is AMN Healthcare Services (AMN) Stock Outpacing Its Business Services Peers This Year?
AMN AMN Healthcare Services
FMP Stock News
Original source text
For those looking to find strong Business Services stocks, it is prudent to search for companies in the group that are outperforming their peers. Is AMN Healthcare Services (AMN - Free Report) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the rest of the Business Services sector should help us answer this question.

AMN Healthcare Services is a member of our Business Services group, which includes 234 different companies and currently sits at #10 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.

The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. AMN Healthcare Services is currently sporting a Zacks Rank of #1 (Strong Buy).

Over the past 90 days, the Zacks Consensus Estimate for AMN's full-year earnings has moved 164.8% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.

According to our latest data, AMN has moved about 42.5% on a year-to-date basis. In comparison, Business Services companies have returned an average of -10.1%. This means that AMN Healthcare Services is outperforming the sector as a whole this year.

HireQuest, Inc. (HQI - Free Report) is another Business Services stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 16.3%.

Over the past three months, HireQuest, Inc.'s consensus EPS estimate for the current year has increased 6%. The stock currently has a Zacks Rank #2 (Buy).

To break things down more, AMN Healthcare Services belongs to the Business - Services industry, a group that includes 20 individual companies and currently sits at #68 in the Zacks Industry Rank. This group has lost an average of 13.2% so far this year, so AMN is performing better in this area.

On the other hand, HireQuest, Inc. belongs to the Staffing Firms industry. This 13-stock industry is currently ranked #155. The industry has moved +7.1% year to date.

Going forward, investors interested in Business Services stocks should continue to pay close attention to AMN Healthcare Services and HireQuest, Inc. as they could maintain their solid performance.
2026-06-12 14:18 2mo ago
2026-05-08 13:05 4mo ago
AMN Q1 Earnings & Revenues Beat Estimates, Gross Margin Contracts
AMN AMN Healthcare Services
FMP Stock News
Original source text
Key Takeaways AMN posted Q1 adjusted EPS of $2.10 and revenues of $1.38B, both topping estimates.AMN's Nurse and Allied Solutions revenues surged 173% as labor disruption events added $722M.AMN expects Q2 revenues of $620M-$635M as labor disruption revenues normalize. AMN Healthcare Services, Inc. (AMN - Free Report) delivered adjusted earnings per share (EPS) of $2.10 in the first-quarter 2026, up 367% year over year. The figure surpassed the Zacks Consensus Estimate by 31.3%.

GAAP EPS for the quarter was $1.59 against a loss per share of 3 cents in the year-ago period.

AMN’s Q1 Revenues in DetailAMN Healthcare registered revenues of $1.38 billion in the first quarter, up 100% year over year. The figure surpassed the Zacks Consensus Estimate by 11.9%.

Shares of this company gained nearly 3.1% in yesterday’s after-hours trading. The company’s shares have rallied 44.8% in the year-to-date period against the industry’s decline of 13.1%. However, the S&P 500 Index has increased 8.5% in the same time frame.

Image Source: Zacks Investment Research

AMN Healthcare’s Q1 Segment DetailsAMN Healthcare conducts its business via three reportable segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions.

In the first quarter of 2026, the Nurse and Allied Solutions segment’s revenues totaled $1.13 billion, up 173% year over year. Travel nurse staffing revenues were up 12% year over year, whereas Allied revenues increased 3% year over year. Labor disruption events contributed $722 million in revenues in the quarter. The Zacks Consensus Estimate was pegged at $984 million.

The Physician and Leadership Solutions segment’s revenues totaled $163.9 million, down 6% year over year. Locum tenens revenues were $131 million in the quarter, down 7% year over year. Interim leadership revenues were down 4% year over year. Physician and leadership search businesses saw a revenue increase of 4% year over year. The Zacks Consensus Estimate was pegged at $163 million.

The Technology and Workforce Solutions segment’s revenues totaled $87.1 million, down 15% year over year. Language interpretation services business revenues came in at $69 million in the quarter, down 8% year over year, while the vendor management systems business saw an 18% year-over-year revenue decline to reach $16 million. The Zacks Consensus Estimate was pegged at $85 million.

AMN’s Q1 Margin TrendIn the quarter under review, AMN Healthcare’s gross profit increased 86.2% year over year to $368.8 million. The gross margin contracted 190 basis points (bps) to 26.8%.

Selling, general & administrative expenses fell 47.8% year over year to $218.4 million.

Operating profit totaled $117.2 million, reflecting an increase of 836.8% from the prior-year quarter. The operating margin expanded 670 basis points (bps) to 8.5%.

AMN Healthcare’s Financial PositionAMN Healthcare exited first-quarter 2026 with cash and cash equivalents of $560.7 million compared with $33.9 million at 2025-end. Total debt at the end of first-quarter 2026 was $750 million compared with $775 million at 2025-end.

Net cash provided by operating activities at the end of first-quarter 2026 was $562.5 million compared with $92.7 million a year ago.

AMN’s Q2 GuidanceAMN Healthcare has provided its financial outlook for the second quarter of 2026.

For the second quarter, AMN expects revenues in the range of $620-$635 million, reflecting a decline of 4-6% compared with the prior-year figure, as labor disruption revenues normalize. The Zacks Consensus Estimate is pegged at $627.7 million.

With respect to the Nurse and Allied Solutions segment, the company expects revenues to be down 0-2% year over year. The Physician and Leadership Solutions segment’s revenues are expected to decline 6-8% year over year. The company projects second-quarter revenues in the Technology and Workforce Solutions segment to decrease 14-16% year over year.

Our Take on AMN’s Q1 ResultsAMN Healthcare delivered a standout first-quarter 2026 performance, driven by extraordinary labor disruption activity, strong, rapid response volume, momentum return in international staffing and search and advancement in technology-enabled workforce solutions. Management emphasized that the quarter was defined by AMN’s ability to rapidly scale operations and support multiple large labor disruption events without compromising day-to-day client service.

AMN continued to strengthen its market position in nurse staffing, allied staffing and international recruitment. Excluding the temporary boost from labor disruption activities, Nurse and Allied Solutions revenues marked the first return to traveler volume growth since 2022. Growth in Travel nurse and allied staffing was supported by stronger fill rates, rapid-response placements and improving demand trends. AMN also saw encouraging progress in its international staffing business, following improvements in visa processing trends.

Technology investments remained a bright spot. The enhanced capabilities within the WorkWise workforce platform and the growing adoption of the AMN Passport app are likely to strengthen client engagement, improve hiring efficiency and support long-term retention. Management highlighted that more than 10,000 clinicians were deployed through its AI recruiter during the quarter, underscoring the increasing role of automation and analytics in its operations.

However, softness in Physician and Leadership Solutions remained concerning. Locum tenens revenues and volumes continued to decline amid weaker demand and heightened competition in third-party channels. Technology and Workforce Solutions revenues also fell year over year due to pricing pressure in Language Services and an unfavorable business mix, despite sequential gross margin improvement.

Looking ahead, management remains optimistic about the company’s long-term trajectory, targeting sustainable revenue growth and adjusted EBITDA growth at roughly twice the pace of revenue growth as operational efficiencies and AI adoption continue to expand.

AMN Healthcare’s Zacks Rank & Other Stocks to ConsiderAMN currently carries a Zacks Rank #2 (Buy).

Some other top-ranked stocks in the broader medical space that have announced quarterly results are West Pharmaceutical Services, Inc. (WST - Free Report) , Intuitive Surgical (ISRG - Free Report) and Cardinal Health, Inc. (CAH - Free Report) .

West Pharmaceutical reported first-quarter 2026 EPS of $2.13, which beat the Zacks Consensus Estimate by 26.8%. Revenues of $844.9 million surpassed the Zacks Consensus Estimate by 8.5%. It currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

West Pharmaceutical has a long-term estimated growth rate of 13.9%. WST’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 19.37%.

Intuitive Surgical reported first-quarter 2026 adjusted EPS of $2.50, beating the Zacks Consensus Estimate by 20.19%. Revenues of $2.77 billion surpassed the Zacks Consensus Estimate by 6.2%. It currently carries a Zacks Rank of 2.

Intuitive Surgical has a long-term estimated growth rate of 14.6%. ISRG’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 16.82%.

Cardinal Health, carrying a Zacks Rank of 2 at present, reported third-quarter fiscal 2026 adjusted EPS of $3.17, which beat the Zacks Consensus Estimate by 13.2%. Revenues of $60.94 billion missed the Zacks Consensus Estimate by 2.3%.

Cardinal Health has a long-term estimated growth rate of 15.7%. CAH’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 10.27%.
2026-06-12 14:18 2mo ago
2026-05-09 07:06 4mo ago
AMN Healthcare Services Q1 Earnings Call Highlights
AMN AMN Healthcare Services
FMP Stock News
Original source text
MarketBeat Instant News Alerts Trending News All MarketBeat Instant News Alerts Sort By

Time Frame

Alert Type

Keywords

Page 1 of 323

Get 30 Days of MarketBeat All Access for Free

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools.

Start Your 30-Day Trial

Sign in to your free account to enjoy these benefits

In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer.
2026-06-12 14:18 2mo ago
2026-05-12 09:56 3mo ago
AMN Healthcare: Strong Execution And Rerate Leaves Less Upside Going Forward
AMN AMN Healthcare Services
FMP Stock News
Original source text
AMN Healthcare's Q1 looked strong, but labor disruption revenue drove most of the upside. Excluding disruption revenue, quarterly sales were roughly flat year over year. Management's Q2 guide implies that disruption revenue should fall sharply from Q1's elevated level.
2026-06-12 14:18 2mo ago
2026-05-13 10:02 3mo ago
Eric Palmer Joins AMN Healthcare Board of Directors
AMN AMN Healthcare Services
FMP Stock News
Original source text
DALLAS, May 13, 2026 (GLOBE NEWSWIRE) -- AMN Healthcare, the leader and innovator in total talent solutions for healthcare organizations, announced the election of Eric Palmer to its Board of Directors, effective May 1, 2026.

Palmer is a seasoned healthcare executive with more than 25 years of leadership experience across healthcare services, benefits, and insurance industries. He has a strong track record of leading large-scale operations, driving strategic growth initiatives, and executing complex mergers, acquisitions, and divestitures.

“Eric’s extensive leadership experience, understanding of the healthcare ecosystem and alignment to our mission make him a valuable addition to our Board,” said Cary Grace, President and CEO of AMN Healthcare. “His proven ability to scale complex organizations and navigate dynamic market environments will strengthen our governance and support AMN’s long-term growth strategy.”

Palmer most recently served as Chief Executive Officer of Evernorth Health Services, where he led the organization’s growth to more than $200 billion in revenue, establishing it as a market leader in specialty pharmacy, pharmacy benefits, and care management services. Prior to that, he served as Chief Financial Officer of Cigna, where he played a central role in driving the transformational acquisition of Express Scripts, successfully combining two Fortune 100 companies.

“AMN’s commitment to empowering healthcare organizations and professionals deeply aligns with the work I’ve done throughout my career,” said Palmer. “I am honored to join the Board and am excited to support AMN’s mission to empower high-quality care through innovative workforce solutions.”

Palmer currently serves on the board of directors of LifeStance Health and is on the board of trustees of Kingswood-Oxford School and Connecticut Children’s Medical Center.

For more information about AMN Healthcare’s leadership team, please visit www.amnhealthcare.com.

About AMN Healthcare
AMN Healthcare is the leader and innovator in total talent solutions for healthcare, bringing together the people, processes and technology to deliver better care. Through a steadfast partnership approach, we solve the most pressing workforce challenges to enable better clinical outcomes and access to care. In 2025 our healthcare professionals reached more than 13 million patients at more than 2,300 healthcare systems, including 93 percent of the top healthcare systems nationwide. We provide a comprehensive network of quality healthcare professionals and deliver a fully integrated and customizable suite of workforce technologies.
2026-06-12 14:18 2mo ago
2026-05-13 14:50 3mo ago
AMN Healthcare Services, Inc. (AMN) Q1 2026 Earnings Call Transcript
AMN AMN Healthcare Services
FMP Stock News
Original source text
AMN Healthcare Services, Inc. (AMN) Q1 2026 Earnings Call Transcript
2026-06-12 14:18 2mo ago
2026-05-14 04:02 3mo ago
AMN Healthcare Services, Inc. (AMN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
AMN AMN Healthcare Services
FMP Stock News
Original source text
AMN Healthcare Services, Inc. (AMN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
2026-06-12 14:18 2mo ago
2026-05-19 10:50 3mo ago
Here's Why AMN Healthcare Services (AMN) is a Strong Momentum Stock
AMN AMN Healthcare Services
FMP Stock News
Original source text
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.

Zacks Premium includes access to the Zacks Style Scores as well.

What are the Zacks Style Scores? Developed alongside the Zacks Rank, the Zacks Style Scores are a group of complementary indicators that help investors pick stocks with the best chances of beating the market over the next 30 days.

Each stock is given an alphabetic rating of A, B, C, D or F based on their value, growth, and momentum qualities. With this system, an A is better than a B, a B is better than a C, and so on, meaning the better the score, the better chance the stock will outperform.

The Style Scores are broken down into four categories:

Value ScoreValue investors love finding good stocks at good prices, especially before the broader market catches on to a stock's true value. Utilizing ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and many other multiples, the Value Style Score identifies the most attractive and most discounted stocks.

Growth ScoreGrowth investors, on the other hand, are more concerned with a company's financial strength and health, and its future outlook. The Growth Style Score examines things like projected and historic earnings, sales, and cash flow to find stocks that will experience sustainable growth over time.

Momentum ScoreMomentum traders and investors live by the saying "the trend is your friend." This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable times to build a position in high-momentum stocks.

VGM ScoreIf you want a combination of all three Style Scores, then the VGM Score will be your friend. It rates each stock on their combined weighted styles, helping you find the companies with the most attractive value, best growth forecast, and most promising momentum. It's also one of the best indicators to use with the Zacks Rank.

How Style Scores Work with the Zacks Rank A proprietary stock-rating model, the Zacks Rank utilizes the power of earnings estimate revisions, or changes to a company's earnings outlook, to help investors create a successful portfolio.

It's highly successful, with #1 (Strong Buy) stocks producing an unmatched +23.7% average annual return since 1988. That's more than double the S&P 500. But because of the large number of stocks we rate, there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.

With more than 800 top-rated stocks to choose from, it can certainly feel overwhelming to pick the ones that are right for you and your investing journey.

That's where the Style Scores come in.

You want to make sure you're buying stocks with the highest likelihood of success, and to do that, you'll need to pick stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you like a stock that only has a #3 (Hold) rank, it should also have Scores of A or B to guarantee as much upside potential as possible.

As mentioned above, the Scores are designed to work with the Zacks Rank, so any change to a company's earnings outlook should be a deciding factor when picking which stocks to buy.

For instance, a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one that boasts Scores of A and B, still has a downward-trending earnings forecast, and a much greater likelihood its share price will decline as well.

Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.

Stock to Watch: AMN Healthcare Services (AMN - Free Report) AMN Healthcare Services, Inc. (AMN - Free Report) , operating from Dallas, TX, is a travel healthcare staffing company. Its business has evolved beyond traditional healthcare staffing and recruitment services, thereby becoming a strategic total talent solutions partner with its clients. It has expanded its portfolio to serve a diverse and growing set of healthcare talent-related needs. In addition to its healthcare professional staffing and recruitment services, AMN’s suite of healthcare workforce solutions includes MSP, vendor management systems (VMS), medical language interpretation services, predictive labor analytics, workforce optimization technology and consulting, recruitment process outsourcing (RPO), revenue cycle solutions, credentialing services and virtual care management services. AMN enables its clients to build, manage and optimize their healthcare talent to deliver improved patient outcomes and experience. It continues to enhance its platform with technology-enabled solutions, including digital workforce platforms, automation tools and AI-driven capabilities to improve speed, efficiency and clinician engagement.

AMN is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.

Momentum investors should take note of this Business Services stock. AMN has a Momentum Style Score of A, and shares are up 41.1% over the past four weeks.

Two analysts revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $0.57 to $2.53 per share. AMN boasts an average earnings surprise of +53.3%.

With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, AMN should be on investors' short list.
2026-06-12 14:18 2mo ago
2026-05-21 09:36 3mo ago
Is the Options Market Predicting a Spike in AMN Healthcare Services Stock?
AMN AMN Healthcare Services
FMP Stock News
Original source text
Investors in AMN Healthcare Services (AMN - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 18, 2026 $05.00 Call had some of the highest implied volatility of all equity options today.

What is Implied Volatility?Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.

What do the Analysts Think?Clearly, options traders are pricing in a big move for AMN Healthcare Services share, but what is the fundamental picture for the company? Currently, AMN Healthcare Services is a Zacks Rank #3 (Hold) in the Business - Services Industry that ranks in the Top 39% of our Zacks Industry Rank. Over the last 60 days, one analyst has increased his estimate for the current quarter, while none have revised their estimates downward. The net effect has taken our Zacks Consensus Estimate for the current quarter to move from 10 cents per share to 188 cents per share in the same time period.

Given the way analysts feel about AMN Healthcare Services right now, this huge implied volatility could mean there’s a trade developing. Often times, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.
2026-06-12 14:18 2mo ago
2026-05-29 10:40 3mo ago
AMN Healthcare Services (AMN) is a Top-Ranked Value Stock: Should You Buy?
AMN AMN Healthcare Services
FMP Stock News
Original source text
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.

Zacks Premium also includes the Zacks Style Scores.

What are the Zacks Style Scores? The Zacks Style Scores, developed alongside the Zacks Rank, are complementary indicators that rate stocks based on three widely-followed investing methodologies; they also help investors pick stocks with the best chances of beating the market over the next 30 days.

Each stock is assigned a rating of A, B, C, D, or F based on their value, growth, and momentum characteristics. Just like in school, an A is better than a B, a B is better than a C, and so on -- that means the better the score, the better chance the stock will outperform.

The Style Scores are broken down into four categories:

Value ScoreFor value investors, it's all about finding good stocks at good prices, and discovering which companies are trading under their true value before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to help pick out the most attractive and discounted stocks.

Growth ScoreWhile good value is important, growth investors are more focused on a company's financial strength and health, and its future outlook. The Growth Style Score takes projected and historic earnings, sales, and cash flow into account to uncover stocks that will see long-term, sustainable growth.

Momentum ScoreMomentum traders and investors live by the saying "the trend is your friend." This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable times to build a position in high-momentum stocks.

VGM ScoreWhat if you like to use all three types of investing? The VGM Score is a combination of all Style Scores, making it one of the most comprehensive indicators to use with the Zacks Rank. It rates each stock on their combined weighted styles, which helps narrow down the companies with the most attractive value, best growth forecast, and most promising momentum.

How Style Scores Work with the Zacks Rank The Zacks Rank is a proprietary stock-rating model that harnesses the power of earnings estimate revisions, or changes to a company's earnings expectations, to help investors build a successful portfolio.

#1 (Strong Buy) stocks have produced an unmatched +23.7% average annual return since 1988, which is more than double the S&P 500's performance over the same time frame. However, the Zacks Rank examines a ton of stocks, and there can be more than 200 companies with a Strong Buy rank, and another 600 with a #2 (Buy) rank, on any given day.

This totals more than 800 top-rated stocks, and it can be overwhelming to try and pick the best stocks for you and your portfolio.

That's where the Style Scores come in.

To have the best chance of big returns, you'll want to always consider stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B, which will give you the highest probability of success. If you're looking at stocks with a #3 (Hold) rank, it's important they have Scores of A or B as well to ensure as much upside potential as possible.

As mentioned above, the Scores are designed to work with the Zacks Rank, so any change to a company's earnings outlook should be a deciding factor when picking which stocks to buy.

Here's an example: a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one with Style Scores of A and B, still has a downward-trending earnings outlook, and a bigger chance its share price will decrease too.

Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.

Stock to Watch: AMN Healthcare Services (AMN - Free Report) AMN Healthcare Services, Inc. (AMN - Free Report) , operating from Dallas, TX, is a travel healthcare staffing company. Its business has evolved beyond traditional healthcare staffing and recruitment services, thereby becoming a strategic total talent solutions partner with its clients. It has expanded its portfolio to serve a diverse and growing set of healthcare talent-related needs. In addition to its healthcare professional staffing and recruitment services, AMN’s suite of healthcare workforce solutions includes MSP, vendor management systems (VMS), medical language interpretation services, predictive labor analytics, workforce optimization technology and consulting, recruitment process outsourcing (RPO), revenue cycle solutions, credentialing services and virtual care management services. AMN enables its clients to build, manage and optimize their healthcare talent to deliver improved patient outcomes and experience. It continues to enhance its platform with technology-enabled solutions, including digital workforce platforms, automation tools and AI-driven capabilities to improve speed, efficiency and clinician engagement.

AMN is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.

It also boasts a Value Style Score of A thanks to attractive valuation metrics like a forward P/E ratio of 11.05; value investors should take notice.

For fiscal 2026, two analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.57 to $2.53 per share. AMN boasts an average earnings surprise of +53.3%.

With a solid Zacks Rank and top-tier Value and VGM Style Scores, AMN should be on investors' short list.
2026-06-12 14:18 2mo ago
2026-06-02 13:01 3mo ago
Here's Why You Should Retain AMN Stock in Your Portfolio for Now
AMN AMN Healthcare Services
FMP Stock News
Original source text
Key Takeaways AMN shares are up 86.1% YTD, even as the industry declined 17.4% over the same stretch.AMN posted $722M labor disruption revenues in Q1 2026, handling five events and deploying thousands.AMN faces tech and language pricing pressure: segment revenues fell 15% YoY and language services lost 8%. AMN Healthcare Services, Inc. (AMN - Free Report) is well-poised for growth in the coming quarters, courtesy of its broad array of services. The optimism is led by strong momentum in its Managed Services Program (MSP), rising labor disruption demand and investments in technology and AI-driven platforms. However, industry shifts, pricing pressure and healthcare cost-consciousness are major downsides.

Shares of this Zacks Rank #3 (Hold) company have jumped 86.1% in the year-to-date period against the industry's 17.4% decline. However, the S&P 500 Index has risen 11.1% in the said timeframe.

This renowned player in the healthcare total talent services space has a market capitalization of $1.12 billion. The company projects 98.5% of earnings growth for 2026 and expects to witness continued improvements in its business. AMN Healthcare surpassed the Zacks Consensus Estimate in all the trailing four quarters, delivering an average earnings surprise of 53.25%.

Image Source: Zacks Investment Research

Factors Favoring AMN StockHealthcare MSP: AMN Healthcare continues to expand its Managed Services Program (MSP) presence as healthcare organizations seek more efficient workforce management solutions. During first-quarter 2026, management noted that many clients have shifted their focus from reducing contract labor usage to optimizing total workforce costs through predictive analytics, workforce planning and technology-enabled staffing strategies.

First-quarter 2026 results highlighted the model’s scalability during multiple labor disruption events, and management added a new locum MSP client and expanded its largest locums contract. As healthcare providers seek strategic workforce partners rather than transactional staffing vendors, AMN’s MSP capabilities position it to deepen client relationships, improve retention and capture additional market share over time.

AI and Workforce Technology Investments Enhancing Scalability: AMN Healthcare continues to invest in AI, automation and analytics to improve hiring efficiency and clinician engagement. In first-quarter 2026, travel nurse revenues rose 13% year over year, allied revenues increased 3%, international staffing returned to growth and leadership search expanded. AMN also demonstrated rapid scalability during major labor disruptions. Through its WorkWise workforce technology platform, the company rolled out AI-driven candidate scoring, search and job-description tools. Its AI recruiter deployed over 10,000 clinicians. AMN Passport users grew over 30%, monthly active users rose over 50% and language services delivered sequential gross margin improvement.

Labor Disruption Capabilities Creating a Competitive Advantage: AMN’s ability to support multiple large labor disruption events emerged as a major strength in the first quarter of 2026. The company generated $722 million in labor disruption revenues while successfully managing five labor disruption events. Management highlighted that investments in event management systems, AI-enabled recruiting tools and scalable operating processes allowed AMN to rapidly deploy thousands of clinicians.

These capabilities strengthen relationships with strategic healthcare clients and reinforce AMN’s position as a trusted workforce partner during critical situations. The company believes this level of execution would not have been possible a few years ago, underscoring the value of its technology investments and broad clinician network.

Downsides of AMN StockHealthcare Cost-Consciousness Limiting Growth: Hospital systems remain heavily focused on workforce cost management despite improving patient utilization trends. Clients continue to prioritize efficiency, predictive workforce planning and labor optimization rather than expanding staffing budgets.

Bill-rate growth remains limited, with increases largely occurring only when difficult-to-fill positions create urgent staffing needs. AMN noted that healthcare providers are increasingly evaluating technology, analytics and workforce planning tools to improve internal staffing efficiency. Continued emphasis on cost containment could restrict demand growth, slow pricing recovery and create a challenging environment for staffing providers across several service lines.

Continued Pricing Pressure in Technology and Language Services: AMN’s Technology and Workforce Solutions segment remains under pressure from competitive pricing dynamics. Segment revenues declined 15% year over year, while language services revenues fell 8%. Management indicated that pricing pressure persists across the language services market, although conditions have become more stable than in prior periods.

The company has implemented service model changes, including greater offshore utilization and operational efficiencies, to protect profitability. However, management expects competition to remain intense and acknowledged that pricing headwinds could continue as contracts renew, creating ongoing pressure on revenue growth and margins.

Healthcare Industry Regulations: AMN Healthcare operates in a highly regulated industry subject to federal and state laws governing reimbursement, workforce practices, privacy, cybersecurity and AI usage. Although clients pay AMN directly, changes in Medicare and Medicaid reimbursement can indirectly affect demand and pricing, while client non-compliance may reduce business activity. The company also serves government clients and must meet specific regulatory requirements. Increasing regulation could raise compliance costs and operational risks. In addition, changes in immigration policies remain an important variable for international nurse staffing, which returned to year-over-year growth in first-quarter 2026 after a period of weakness.

Estimate TrendAMN Healthcare has been witnessing a positive estimate revision trend for 2026. Over the past 60 days, the Zacks Consensus Estimate for its earnings per share has improved 37.7% to $2.70.

The Zacks Consensus Estimate for second-quarter 2026 revenues and earnings per share is pegged at $625.7 million and 22 cents, respectively, suggesting 4.9% and 26.7% declines from the year-ago reported numbers.

Key PicksSome better-ranked stocks in the broader medical space are West Pharmaceutical Services (WST - Free Report) , Align Technology (ALGN - Free Report) and Biodesix (BDSX - Free Report) . While West Pharmaceutical Services and Align Technology sport a Zacks Rank #1 (Strong Buy) each at present, Biodesix carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

West Pharmaceutical Services has an estimated long-term growth rate of 13.9%. WST's earnings surpassed estimates in each of the trailing four quarters, with the average being 19.4%.

West Pharmaceutical Services’ stock has gained 14.9% against the industry's 9.3% decline in the year-to-date period.

Align Technology's earnings surpassed estimates in three of the trailing four quarters and missed one, with the average surprise being 7.8%.

ALGN's shares have risen 8.7% in the year-to-date period against the industry’s 9.3% decline.

Biodesix's earnings surpassed estimates in three of the trailing four quarters and missed one, with the average surprise being 25.6%.

BDSX's shares have rallied 124.6% in the year-to-date period against the industry’s 9.7% decline.
2026-06-12 14:18 2mo ago
2026-06-05 10:51 3mo ago
Why AMN Healthcare Services (AMN) is a Top Momentum Stock for the Long-Term
AMN AMN Healthcare Services
FMP Stock News
Original source text
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.

It also includes access to the Zacks Style Scores.

What are the Zacks Style Scores? The Zacks Style Scores, developed alongside the Zacks Rank, are complementary indicators that rate stocks based on three widely-followed investing methodologies; they also help investors pick stocks with the best chances of beating the market over the next 30 days.

Each stock is given an alphabetic rating of A, B, C, D or F based on their value, growth, and momentum qualities. With this system, an A is better than a B, a B is better than a C, and so on, meaning the better the score, the better chance the stock will outperform.

The Style Scores are broken down into four categories:

Value ScoreValue investors love finding good stocks at good prices, especially before the broader market catches on to a stock's true value. Utilizing ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and many other multiples, the Value Style Score identifies the most attractive and most discounted stocks.

Growth ScoreGrowth investors, on the other hand, are more concerned with a company's financial strength and health, and its future outlook. The Growth Style Score examines things like projected and historic earnings, sales, and cash flow to find stocks that will experience sustainable growth over time.

Momentum ScoreMomentum trading is all about taking advantage of upward or downward trends in a stock's price or earnings outlook, and these investors live by the saying "the trend is your friend." The Momentum Style Score can pinpoint good times to build a position in a stock, using factors like one-week price change and the monthly percentage change in earnings estimates.

VGM ScoreWhat if you like to use all three types of investing? The VGM Score is a combination of all Style Scores, making it one of the most comprehensive indicators to use with the Zacks Rank. It rates each stock on their combined weighted styles, which helps narrow down the companies with the most attractive value, best growth forecast, and most promising momentum.

How Style Scores Work with the Zacks Rank The Zacks Rank is a proprietary stock-rating model that harnesses the power of earnings estimate revisions, or changes to a company's earnings expectations, to help investors build a successful portfolio.

#1 (Strong Buy) stocks have produced an unmatched +23.7% average annual return since 1988, which is more than double the S&P 500's performance over the same time frame. However, the Zacks Rank examines a ton of stocks, and there can be more than 200 companies with a Strong Buy rank, and another 600 with a #2 (Buy) rank, on any given day.

But it can feel overwhelming to pick the right stocks for you and your investing goals with over 800 top-rated stocks to choose from.

That's where the Style Scores come in.

To maximize your returns, you want to buy stocks with the highest probability of success. This means picking stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you find yourself looking at stocks with a #3 (Hold) rank, make sure they have Scores of A or B as well to ensure as much upside potential as possible.

Since the Scores were created to work together with the Zacks Rank, the direction of a stock's earnings estimate revisions should be a key factor when choosing which stocks to buy.

A stock with a #4 (Sell) or #5 (Strong Sell) rating, for instance, even one with Scores of A and B, will still have a declining earnings forecast, and a greater chance its share price will fall too.

Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.

Stock to Watch: AMN Healthcare Services (AMN - Free Report) AMN Healthcare Services, Inc. (AMN - Free Report) , operating from Dallas, TX, is a travel healthcare staffing company. Its business has evolved beyond traditional healthcare staffing and recruitment services, thereby becoming a strategic total talent solutions partner with its clients. It has expanded its portfolio to serve a diverse and growing set of healthcare talent-related needs. In addition to its healthcare professional staffing and recruitment services, AMN’s suite of healthcare workforce solutions includes MSP, vendor management systems (VMS), medical language interpretation services, predictive labor analytics, workforce optimization technology and consulting, recruitment process outsourcing (RPO), revenue cycle solutions, credentialing services and virtual care management services. AMN enables its clients to build, manage and optimize their healthcare talent to deliver improved patient outcomes and experience. It continues to enhance its platform with technology-enabled solutions, including digital workforce platforms, automation tools and AI-driven capabilities to improve speed, efficiency and clinician engagement.

AMN is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.

Momentum investors should take note of this Business Services stock. AMN has a Momentum Style Score of A, and shares are up 36.4% over the past four weeks.

Three analysts revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $0.74 to $2.70 per share. AMN boasts an average earnings surprise of +53.3%.

With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, AMN should be on investors' short list.
2026-06-12 14:18 2mo ago
2026-06-08 12:18 3mo ago
AMN Healthcare Services, Inc. (AMN) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
AMN AMN Healthcare Services
FMP Stock News
Original source text
AMN Healthcare Services, Inc. (AMN) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
2026-06-12 14:18 2mo ago
2026-06-10 11:41 3mo ago
AMN Expands Language Services Portfolio With Jaide Health Deal
AMN AMN Healthcare Services
FMP Stock News
Original source text
Key Takeaways AMN acquired Jaide Health to expand language access for patients with Limited English Proficiency.AMN adds AI-assisted translation for intake, discharge and routine interactions, plus documents.Jaide's team joins AMN; terms weren't disclosed, and human interpreters stay key for complex talks. AMN Healthcare Services (AMN - Free Report) recently announced the acquisition of Jaide Health, an AI-enabled medical interpretation and translation platform, to expand language access for patients with Limited English Proficiency across the healthcare journey. The move enhances AMN’s Language Services capabilities by extending language assistance to important touchpoints before and after treatment while maintaining the critical role of qualified human interpreters for clinical, sensitive and complex discussions.

According to management, this acquisition represents a significant step forward in AMN’s commitment to making healthcare more accessible. Enhancing language support across more moments in the healthcare journey enables healthcare organizations to create seamless experiences for both patients and care teams, while still leveraging the critical expertise of qualified interpreters.

AMN Stock Trend Following the NewsFollowing the announcement, shares of AMN lost 2.3% at yesterday’s closing. In the year-to-date period, the stock surged 92.4% against the industry’s 17.9% decline. The S&P 500 has risen 8.3% in the same timeframe.

The integration of AI-assisted translation capabilities enables AMN Healthcare to offer more comprehensive end-to-end language support while preserving the critical role of human interpreters. The transaction also reflects the increasing adoption of AI solutions in healthcare administration. By combining technology-driven efficiency with human expertise, AMN is well positioned to help healthcare organizations address the rising demand for accessible and equitable patient communication.

AMN currently has a market capitalization of $1.20 billion.

Image Source: Zacks Investment Research

More on the NewsJaide Health delivers AI-assisted language support for routine verbal interactions and document translations, including patient intake, discharge instructions and other everyday communications.These capabilities reduce delays and improve language accessibility in situations where healthcare staff and patients often face communication barriers outside direct physician or acute-care encounters.For complex medical conversations, professional human interpreters remain central to ensure accuracy, empathy and patient safety.

The Jaide Health platform is already being used by clients across multiple care settings, demonstrating its ability to improve communication workflows and patient interactions. As part of the transaction, Jaide Health’s team will become part of AMN Healthcare. The companies have not disclosed the financial details of the agreement.

Industry Prospects Favoring the MarketGoing by the data provided by Precedence Research, the AI-enabled translation services market was valued at $6.51 billion in 2026 and is expected to witness a CAGR of 25.6% through 2035.

Factors like the increasing demand for real-time translators, rapid adoption by the healthcare sector and the advancements in LLMs and GenAI that offer precise and context-aware translation services with cost efficiency are boosting the market’s growth.

Other NewsAMN Healthcare recently delivered a strong first-quarter 2026 performance, fueled by labor disruption activity, growth in nurse and allied staffing, improving international recruitment and expanding technology-driven workforce solutions. The company’s AI-powered tools and the WorkWise platform continued to gain traction, enhancing hiring efficiency. However, weakness in Physician and Leadership Solutions persisted due to softer demand and competitive pressures. Management expects AI adoption and operational efficiencies to support sustainable revenue and profitability growth.

AMN’s Zacks Rank & Key PicksAMN Healthcare currently carries a Zacks Rank #3 (Hold).

Some better-ranked stocks from the broader medical space are West Pharmaceutical (WST - Free Report) , Globus Medical (GMED - Free Report) and Biodesix (BDSX - Free Report) .

West Pharmaceutical, sporting a Zacks Rank #1 (Strong Buy) at present, reported first-quarter 2026 earnings per share (EPS) of $2.13, which beat the Zacks Consensus Estimate by 26.8%. Revenues of $844.9 million surpassed the Zacks Consensus Estimate by 8.5%. You can see the complete list of today’s Zacks #1 Rank stocks here.

West Pharmaceutical has an estimated long-term earnings growth rate of 13.9%. WST’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 19.4%.

Globus Medical, currently carrying a Zacks Rank #2 (Buy), reported first-quarter 2026 adjusted EPS of $1.12, which surpassed the Zacks Consensus Estimate by 22.1%. Revenues of $759.9 million beat the Zacks Consensus Estimate by 4.0%.

Globus Medical has an estimated long-term earnings growth rate of 10.2%. GMED’s earnings beat estimates in each of the trailing four quarters, the average surprise being 26.3%.

Biodesix, currently carrying a Zacks Rank of 2, reported a first-quarter 2026 adjusted loss per share of 81 cents, which came narrower than the Zacks Consensus Estimate by 35.71%. Revenues of $26 million beat the Zacks Consensus Estimate by 12.3%.

BDSX has an estimated earnings growth rate of 36% for 2026. The company beat earnings estimates in three of the trailing four quarters and missed once, with the average surprise being 25.5%.
2026-06-12 14:18 2mo ago
2026-03-19 12:31 5mo ago
Element Solutions (ESI) Down 6.1% Since Last Earnings Report: Can It Rebound?
ESI Element Solutions
FMP Stock News
Original source text
A month has gone by since the last earnings report for Element Solutions (ESI - Free Report) . Shares have lost about 6.1% in that time frame, underperforming the S&P 500.

Will the recent negative trend continue leading up to its next earnings release, or is Element Solutions due for a breakout? Well, first let's take a quick look at its most recent earnings report in order to get a better handle on the recent drivers for Element Solutions Inc. before we dive into how investors and analysts have reacted as of late.

Element Solutions’ Q4 Earnings & Revenues Surpass EstimatesElement Solutions recorded earnings of 3 cents per share for the fourth quarter of 2025 compared with 23 cents in the year-ago quarter.  

Barring one-time items, earnings were 37 cents per share. The figure beat the Zacks Consensus Estimate of 36 cents.  

The company generated net sales of $676.2 million, up roughly 8% year over year. The figure beat the Zacks Consensus Estimate of $623.9 million. Organic net sales rose 10%.  

Element Solutions saw strong growth in the electronics business. The divestitures impacted the Specialties segment sales in the quarter. 

Segment HighlightsNet sales in the Electronics segment rose 21% year over year to $487.3 million in the reported quarter. Organic net sales were up 13% from the year-ago number. The figure beat the consensus estimate of $436 million.  

In the Specialties segment, net sales declined 15% year over year to $188.9 million, with organic net sales increasing by 4%. However, the figure beat the consensus estimate of $188 million.  

Financial PositionElement Solutions ended the quarter with cash and cash equivalents of $626.5 million, up around 74.3% from the year-ago quarter. Long-term debt was $1,625.9 million at the end of the quarter, down from $1,813.6 million a year ago.  

Cash from operating activities was $91.1 million, while free cash flow was $82.8 million for the reported quarter.  

Q1 & 2026 OutlookThe company anticipates full-year 2026 adjusted EBITDA in the range of $650 million to $670 million. Element Solutions expects first-quarter 2026 adjusted EBITDA to be between $140 million and $155 million.

How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a downward trend in estimates review.

VGM ScoresCurrently, Element Solutions has a average Growth Score of C, however its Momentum Score is doing a bit better with a B. Charting a somewhat similar path, the stock was allocated a grade of C on the value side, putting it in the middle 20% for value investors.

Overall, the stock has an aggregate VGM Score of C. If you aren't focused on one strategy, this score is the one you should be interested in.

OutlookEstimates have been broadly trending downward for the stock, and the magnitude of this revision indicates a downward shift. Notably, Element Solutions has a Zacks Rank #2 (Buy). We expect an above average return from the stock in the next few months.
2026-06-12 14:18 2mo ago
2026-03-23 16:30 5mo ago
Element Solutions Inc Announces Board Leadership Transition
ESI Element Solutions
FMP Stock News
Original source text
MIAMI--(BUSINESS WIRE)--Element Solutions Inc (NYSE:ESI) (“Element Solutions” or the “Company”), a global and diversified specialty chemicals technology company, today announced that Sir Martin E. Franklin, Executive Chairman of the Board, plans to step down from the Board and will not seek re-election at the upcoming 2026 Annual Meeting of Stockholders. Ian G.H. Ashken, a founding Board director since 2013 and Chair of the Board's Nominating and Policies Committee, has been appointed Non-Execu.
2026-06-12 14:18 2mo ago
2026-04-07 03:13 5mo ago
Allspring Global Investments Holdings LLC Sells 117,639 Shares of Element Solutions Inc. $ESI
ESI Element Solutions
FMP Stock News
Original source text
Posted by Defense World Staff on Apr 7th, 2026

Allspring Global Investments Holdings LLC lowered its stake in shares of Element Solutions Inc. (NYSE:ESI – Free Report) by 29.1% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 286,958 shares of the company’s stock after selling 117,639 shares during the quarter. Allspring Global Investments Holdings LLC owned approximately 0.12% of Element Solutions worth $7,444,000 as of its most recent SEC filing.

Several other institutional investors have also bought and sold shares of ESI. Walnut Level Capital LLC purchased a new position in Element Solutions in the second quarter valued at approximately $1,812,000. Vest Financial LLC lifted its stake in Element Solutions by 126.1% in the third quarter. Vest Financial LLC now owns 115,531 shares of the company’s stock valued at $2,908,000 after purchasing an additional 64,433 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in Element Solutions by 1.7% during the third quarter. Dimensional Fund Advisors LP now owns 8,256,926 shares of the company’s stock worth $207,822,000 after purchasing an additional 139,751 shares during the period. World Investment Advisors bought a new position in Element Solutions during the third quarter worth about $1,185,000. Finally, American Century Companies Inc. increased its stake in shares of Element Solutions by 28.0% in the third quarter. American Century Companies Inc. now owns 4,195,840 shares of the company’s stock worth $105,609,000 after purchasing an additional 916,804 shares in the last quarter. Hedge funds and other institutional investors own 92.32% of the company’s stock.

Analysts Set New Price Targets Several analysts have recently issued reports on the stock. Truist Financial boosted their price target on shares of Element Solutions from $33.00 to $38.00 and gave the company a “buy” rating in a research report on Thursday, February 19th. KeyCorp boosted their price target on shares of Element Solutions from $34.00 to $36.00 and gave the company an “overweight” rating in a research report on Thursday, February 19th. BMO Capital Markets boosted their price target on shares of Element Solutions from $35.00 to $37.00 and gave the company an “outperform” rating in a research report on Wednesday, February 18th. Freedom Capital raised shares of Element Solutions to a “strong-buy” rating in a research report on Friday, March 27th. Finally, Bank of America boosted their price target on shares of Element Solutions from $31.00 to $33.00 and gave the company a “buy” rating in a research report on Monday, January 26th. Three investment analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average price target of $35.75.

View Our Latest Report on ESI

Element Solutions Trading Down 0.4% Shares of Element Solutions stock opened at $33.95 on Tuesday. Element Solutions Inc. has a 12-month low of $16.77 and a 12-month high of $37.74. The company has a market cap of $8.27 billion, a price-to-earnings ratio of 42.98, a PEG ratio of 1.56 and a beta of 1.23. The company has a current ratio of 3.68, a quick ratio of 3.00 and a debt-to-equity ratio of 0.60. The company’s 50-day moving average price is $32.58 and its 200-day moving average price is $28.54.

Element Solutions (NYSE:ESI – Get Free Report) last announced its quarterly earnings results on Tuesday, February 17th. The company reported $0.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.36 by $0.01. Element Solutions had a net margin of 7.48% and a return on equity of 13.79%. The firm had revenue of $676.20 million for the quarter, compared to the consensus estimate of $632.40 million. During the same period in the prior year, the firm posted $0.35 earnings per share. The company’s revenue for the quarter was up 8.3% on a year-over-year basis. On average, equities analysts expect that Element Solutions Inc. will post 1.45 earnings per share for the current fiscal year.

Element Solutions Announces Dividend The company also recently declared a quarterly dividend, which was paid on Monday, March 16th. Stockholders of record on Monday, March 2nd were issued a $0.08 dividend. This represents a $0.32 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend was Monday, March 2nd. Element Solutions’s dividend payout ratio is presently 40.51%.

Insider Activity In other news, Director E Stanley Oneal sold 143,564 shares of the stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $35.52, for a total value of $5,099,393.28. Following the sale, the director directly owned 147,832 shares of the company’s stock, valued at approximately $5,250,992.64. This represents a 49.27% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 6.90% of the company’s stock.

Element Solutions Company Profile (Free Report)

Element Solutions Inc is a global specialty chemicals company that develops and supplies highly engineered chemistries to performance-driven end markets. The company’s solutions serve customers across the electronics, energy, transportation, consumer and industrial sectors, with a particular emphasis on electronics chemicals, metal plating, and industrial coatings additives.

In the electronics market, Element Solutions provides a range of plating and surface-treatment chemistries used in the manufacture of printed circuit boards, semiconductor devices, and advanced display technologies.

Featured Articles Five stocks we like better than Element Solutions Want to see what other hedge funds are holding ESI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Element Solutions Inc. (NYSE:ESI – Free Report).

Receive News & Ratings for Element Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Element Solutions and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAllspring Global Investments Holdings LLC Buys 8,381 Shares of Molina Healthcare, Inc $MOH

NEXT HEADLINE »Allspring Global Investments Holdings LLC Sells 15,739 Shares of Patrick Industries, Inc. $PATK
2026-06-12 14:18 2mo ago
2026-04-14 10:41 4mo ago
Are Basic Materials Stocks Lagging Element Solutions (ESI) This Year?
ESI Element Solutions
FMP Stock News
Original source text
For those looking to find strong Basic Materials stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Element Solutions (ESI - Free Report) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out.

Element Solutions is one of 248 individual stocks in the Basic Materials sector. Collectively, these companies sit at #14 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.

The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. Element Solutions is currently sporting a Zacks Rank of #2 (Buy).

Within the past quarter, the Zacks Consensus Estimate for ESI's full-year earnings has moved 3.8% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.

Based on the latest available data, ESI has gained about 52.1% so far this year. At the same time, Basic Materials stocks have gained an average of 19.6%. This shows that Element Solutions is outperforming its peers so far this year.

Teck Resources Ltd (TECK - Free Report) is another Basic Materials stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 19.9%.

For Teck Resources Ltd, the consensus EPS estimate for the current year has increased 50.1% over the past three months. The stock currently has a Zacks Rank #2 (Buy).

Breaking things down more, Element Solutions is a member of the Chemical - Specialty industry, which includes 44 individual companies and currently sits at #171 in the Zacks Industry Rank. This group has gained an average of 13.1% so far this year, so ESI is performing better in this area.

On the other hand, Teck Resources Ltd belongs to the Mining - Miscellaneous industry. This 72-stock industry is currently ranked #145. The industry has moved +21.8% year to date.

Investors interested in the Basic Materials sector may want to keep a close eye on Element Solutions and Teck Resources Ltd as they attempt to continue their solid performance.
2026-06-12 14:18 2mo ago
2026-04-14 16:30 4mo ago
Element Solutions Inc Announces Date for 2026 First Quarter Earnings Release
ESI Element Solutions
FMP Stock News
Original source text
MIAMI--(BUSINESS WIRE)--Element Solutions Inc (NYSE:ESI) ("Element Solutions") announced today that it intends to release its 2026 first quarter financial results after the market close on Tuesday, April 28, 2026. Element Solutions will host a webcast/dial-in conference call to discuss its financial results at 8:30 a.m. (Eastern Time) on Wednesday, April 29, 2026. Participants on the call will include Chief Executive Officer Benjamin Gliklich and Chief Financial Officer Carey J. Dorman. To list.
2026-06-12 14:18 2mo ago
2026-04-28 16:15 4mo ago
Element Solutions Inc Reports Record Quarterly Results and Increases 2026 Full Year Guidance
ESI Element Solutions
FMP Stock News
Original source text
MIAMI--(BUSINESS WIRE)--Element Solutions Inc (NYSE:ESI) (“Element Solutions” or the “Company”), a global and diversified specialty chemicals technology company, today announced its financial results for the three months ended March 31, 2026. Executive Commentary Chief Executive Officer Benjamin Gliklich commented, “Element Solutions had an outstanding start to the year. We delivered double-digit organic net sales growth and strong margin expansion while ramping our investments to keep pace wit.
2026-06-12 14:18 2mo ago
2026-04-28 20:01 4mo ago
Element Solutions (ESI) Surpasses Q1 Earnings and Revenue Estimates
ESI Element Solutions
FMP Stock News
Original source text
Element Solutions (ESI - Free Report) came out with quarterly earnings of $0.41 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.34 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +7.90%. A quarter ago, it was expected that this specialty chemical and printing products would post earnings of $0.36 per share when it actually produced earnings of $0.37, delivering a surprise of +2.78%.

Over the last four quarters, the company has surpassed consensus EPS estimates four times.

Element Solutions, which belongs to the Zacks Chemical - Specialty industry, posted revenues of $840 million for the quarter ended March 2026, surpassing the Zacks Consensus Estimate by 12.85%. This compares to year-ago revenues of $593.7 million. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Element Solutions shares have added about 61.5% since the beginning of the year versus the S&P 500's gain of 4.8%.

What's Next for Element Solutions?While Element Solutions has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Element Solutions was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.44 on $795.45 million in revenues for the coming quarter and $1.76 on $3.19 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Chemical - Specialty is currently in the bottom 26% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

One other stock from the same industry, Celanese (CE - Free Report) , is yet to report results for the quarter ended March 2026. The results are expected to be released on May 5.

This chemical company is expected to post quarterly earnings of $0.84 per share in its upcoming report, which represents a year-over-year change of +47.4%. The consensus EPS estimate for the quarter has been revised 10.4% higher over the last 30 days to the current level.

Celanese's revenues are expected to be $2.26 billion, down 5.5% from the year-ago quarter.
2026-06-12 14:18 2mo ago
2026-04-29 09:21 4mo ago
Element Solutions Tops Earnings and Revenue Estimates in Q1
ESI Element Solutions
FMP Stock News
Original source text
Key Takeaways ESI posted Q1 adjusted EPS of 41 cents, topping the Zacks Consensus Estimate of 38 cents. Net sales surged 41% year over year to $840 million, beating the consensus mark of $744.4 million. The company raised its 2026 adjusted EBITDA outlook to $665 million-$685 million. Element Solutions Inc. (ESI - Free Report) recorded earnings of 23 cents per share for the first quarter of 2026 compared with 40 cents in the year-ago quarter. Reported net income was $56 million, down 43% year over year, primarily due to a gain on the Graphics Solutions divestiture in the prior-year period.  

Barring one-time items, earnings were 41 cents per share, up from 34 cents in the year-ago quarter. The figure beat the Zacks Consensus Estimate of 38 cents. 

The company generated net sales of $840 million, up 41% year over year from $593.7 million. The figure beat the Zacks Consensus Estimate of $744.4 million. Organic net sales rose 10%.  

ESI benefited from strong momentum in its Electronics business, aided by robust demand tied to AI infrastructure, high-performance electronics, advanced packaging and thermal management applications. Acquisitions also contributed to reported growth in the quarter. 

Element Solutions Inc. Price, Consensus and EPS SurpriseESI’s Segment HighlightsNet sales in the Electronics segment rose 61% year over year to $633.5 million in the reported quarter. The figure beat the consensus estimate of $532 million. Organic net sales increased 15%. Adjusted EBITDA for the segment increased 34% year over year to $119.1 million.  

In the Specialties segment, net sales increased 4% year over year to $206.5 million. Organic net sales rose 1%. The figure missed the consensus estimate of $207 million. Adjusted EBITDA for the segment rose 9% year over year to $43.2 million.  

ESI’s Financial PositionElement Solutions ended the quarter with cash and cash equivalents of $177.3 million, down from $626.5 million at the end of 2025. Debt was $2,058.7 million at the end of the quarter compared with $1,625.9 million as of Dec. 31, 2025.  

Cash used in operating activities was $66.6 million against cash provided by operating activities of $26 million in the year-ago quarter. Free cash flow was negative $74.2 million against a positive free cash flow of $30.1 million in the prior-year quarter.  

ESI’s OutlookThe company now expects full-year 2026 adjusted EBITDA in the range of $665 million to $685 million, up from its earlier outlook of $650 million to $670 million. For the second quarter of 2026, ESI expects adjusted EBITDA between $155 million and $170 million.  

ESI’s Price PerformanceShares of Element Solutions have gained 91.7% in a year compared with a 9.8% rise in the ndustry. 

Image Source: Zacks Investment Research

ESI’s Zacks Rank & Key PicksESI currently carries a Zacks Rank #3 (Hold).

Some better-ranked stocks worth a look in the basic materials space are CF Industries Holdings, Inc. (CF - Free Report) , Galiano Gold Inc. (GAU - Free Report)  and Nexa Resources S.A. (NEXA - Free Report) .

CF Industries is slated to report first-quarter 2026 results on May 6. The Zacks Consensus Estimate for earnings is pegged at $2.35 per share, indicating 27.03% year-over-year growth. CF sports a Zacks Rank #1 (Strong Buy) at present.  

Galiano is slated to report quarterly results on May 13. The Zacks Consensus Estimate for earnings is pegged at 17 cents per share. GAU has a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.

NEXA is scheduled to report first-quarter results on May 6. The Zacks Consensus Estimate for NEXA’s first-quarter earnings is pegged at 61 cents per share. NEXA currently has a Zacks Rank #2. 
2026-06-12 14:18 2mo ago
2026-04-29 11:21 4mo ago
Element Solutions Inc (ESI) Q1 2026 Earnings Call Transcript
ESI Element Solutions
FMP Stock News
Original source text
Element Solutions Inc (ESI) Q1 2026 Earnings Call Transcript
2026-06-12 14:18 2mo ago
2026-05-05 09:40 4mo ago
3 Chemical Specialty Stocks to Watch Amid Demand Woes
ESI Element Solutions
FMP Stock News
Original source text
The Zacks Chemicals Specialty industry is facing headwinds from weak demand amid sluggish conditions in Europe, a slow recovery in China and tariff-related disruptions. Profit margins across the sector also remain strained due to persistently high input, supply chain and logistics costs.

Industry players, such as Element Solutions Inc (ESI - Free Report) , Perimeter Solutions, Inc. (PRM - Free Report) and Hawkins, Inc. (HWKN - Free Report) are banking on strategic measures, including operating cost reductions, to tide over a persistently challenging environment.

About the Industry The Zacks Chemicals Specialty industry consists of manufacturers of specialty chemical products for a host of end-use markets such as textile, paper, automotive, electronics, personal care, energy, construction, food & beverages and agriculture. These chemicals (including catalysts, surfactants, specialty polymers, coating additives, pesticides and oilfield chemicals) are used based on their performance and have a specific purpose. Specialty chemicals can be single molecules or a combination of molecules referred to as formulations, and they provide a vast range of effects upon which various industries rely. Their compositions significantly influence the performance of the finished products. Specialty chemicals have applications in the manufacturing process of a vast range of products, including paints and coatings, cosmetics, petroleum products, inks and plastics. 

What's Shaping the Future of the Chemical Specialty Industry? Demand Softness Pose Headwinds: Companies in the chemical specialty space are facing headwinds from weak demand in building and construction as well as industrial end markets, especially in Europe and China, due to economic slowdown. Elevated borrowing costs and inflation have taken a bite out of the residential construction industry. Manufacturing activities have also weakened amid softer demand for goods and higher borrowing costs. A slower recovery in economic activities in China is hurting demand in that country. Low consumer confidence and high inflation have also dampened demand in Europe. While customer inventory de-stocking is essentially complete, some lingering impacts of the same in certain markets are expected to continue over the near term. The imposition of hefty tariffs has also introduced significant headwinds for the chemical specialty industry. The soft demand conditions, exacerbated by the weak macroeconomic environment and tariff-induced impacts, are likely to weigh on the volumes of chemical specialty companies.

Cost Pressure Still a Worry: Specialty chemical makers are facing headwinds from raw-material and energy-cost inflation and supply-chain and freight-transportation disruptions. Some companies are exposed to challenges from elevated logistics and labor costs. Tariffs have led to increased costs for raw materials, resulting in higher production expenses for the industry players. The impacts of inflationary pressures are expected to continue over the short term and weigh on the margins of chemical specialty companies.

Strategic Actions to Aid Results: The companies in this space are executing a raft of self-help measures — including cost-cutting and productivity improvement, expansion into high-growth markets, restructuring, operational efficiency improvement, and actions to strengthen the balance sheet and boost cash flows — in a bid to stay afloat despite the prevailing headwinds. The industry participants are aggressively implementing actions to cut costs. The measures are likely to help companies sail through the ongoing challenges.

Zacks Industry Rank Indicates Downbeat Prospects The Zacks Chemicals Specialty industry is part of the broader Zacks Basic Materials sector. It carries a Zacks Industry Rank #180, which places it in the bottom 27% of more than 250 Zacks industries.

The group’s Zacks Industry Rank, which is basically the average of the Zacks Rank of all the member stocks, indicates a bleak near-term. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Before we present a few stocks that you may want to consider for your portfolio, let’s take a look at the industry’s recent stock-market performance and valuation picture.

Industry Underperforms Sector & S&P 500 The Zacks Chemicals Specialty industry has underperformed the Zacks S&P 500 composite and the broader Zacks Basic Materials sector over the past year.

The industry has gained 5.9% over this period compared with the S&P 500’s rise of 32.8% and the broader sector’s increase of 40.5%.

One-Year Price Performance

Industry's Current Valuation On the basis of the trailing 12-month enterprise value-to EBITDA (EV/EBITDA) ratio, which is a commonly used multiple for valuing chemical stocks, the industry is currently trading at 11.69, below the S&P 500’s 17.69 and the sector’s 14.47.

Over the past three years, the industry has traded as high as 13.12X, as low as 10.56X, with a median of 11.94X, as the chart below shows.

Enterprise Value/EBITDA (EV/EBITDA) Ratio

Enterprise Value/EBITDA (EV/EBITDA) Ratio 

3 Chemical Specialty Stocks to Keep a Close Eye on Element Solutions: Florida-based Element Solutions is a leading specialty chemicals provider, offering innovative and differentiated solutions to its customers across a vast spectrum of industries. ESI is poised for growth, driven by strong execution and strategic positioning in the electronics sector, which underpins its robust long-term growth outlook. The company is benefiting from strength in the electronics market. It is seeing strong organic growth in its Electronics segment. High-value end markets are contributing to a favorable product mix, while the ongoing pricing and productivity initiatives are boosting margins. The Micromax acquisition has strengthened its position to build an industry-leading Electronics portfolio. The acquisition of EFC Gases & Advanced Materials also added higher value and differentiated offerings in specialty and rare gases, along with advanced materials.

ESI has an expected earnings growth of 19.5% for 2026. The Zacks Consensus Estimate for Element Solutions’ 2026 earnings has moved 2.9% upward over the last 60 days. ESI surpassed the Zacks Consensus Estimate in each of the trailing four quarters at an average of roughly 4.7%. ESI currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Price and Consensus: ESI

Perimeter Solutions: Missouri-based Perimeter Solutions is a leading provider of solutions for the fire safety and specialty products industries. It is expected to benefit from the recovery of major end markets. Favorable industry trends are expected to continue to drive demand for fire-retardant products. The company remains focused on expanding its fire prevention and protection business. Its Specialty Products segment is seeing sales growth aided by a recovery from de-stocking activities and an increase in purchases by high-quality specialty chemicals customers. PRM’s strong balance sheet also offers adequate liquidity for growth investments and M&A opportunities.

Perimeter Solutions currently carries a Zacks Rank #2. It has expected earnings growth of 9.7% for 2026. The Zacks Consensus Estimate for PRM’s 2026 earnings has moved up 19.5% over the last 60 days.

Price and Consensus: PRM

Hawkins: Minnesota-based Hawkins is a leading specialty chemical and ingredients company that formulates, distributes, blends and manufactures products for its customers. Hawkins is seeing strong growth in its Water Treatment segment, reflecting its strategic emphasis on the water treatment sector, including the successful integration of recent acquisitions. The acquisition of Industrial Research Corporation aligns with Hawkins’ growth strategy in central and northern Louisiana, eastern Texas and southern Arkansas, complementing its existing operations and enhancing its market presence. The Wofford Water Service buyout also extended HWKN’s reach in Mississippi and supported its expansion in the southern United States, where its Water Treatment business had been limited previously. The Amerochem assets and WaterSurplus acquisitions further strengthened its Water Treatment footprint. HWKN’s judicious pricing strategy to counter cost inflation is also supporting results. It also remains committed to enhancing shareholders’ value.

The Zacks Consensus Estimate for Hawkins’ fiscal 2026 earnings has moved up 0.3% over the last 60 days. Hawkins, carrying a Zacks Rank #2, has an expected long-term earnings per share growth rate of 12%.

Price and Consensus: HWKN
 
2026-06-12 14:18 2mo ago
2026-05-05 10:41 4mo ago
Is Element Solutions (ESI) Outperforming Other Basic Materials Stocks This Year?
ESI Element Solutions
FMP Stock News
Original source text
The Basic Materials group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Element Solutions (ESI - Free Report) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Basic Materials sector should help us answer this question.

Element Solutions is one of 248 companies in the Basic Materials group. The Basic Materials group currently sits at #13 within the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.

The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. Element Solutions is currently sporting a Zacks Rank of #2 (Buy).

Over the past 90 days, the Zacks Consensus Estimate for ESI's full-year earnings has moved 5.5% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.

Based on the most recent data, ESI has returned 71.3% so far this year. Meanwhile, stocks in the Basic Materials group have gained about 12% on average. This means that Element Solutions is outperforming the sector as a whole this year.

Carpenter Technology (CRS - Free Report) is another Basic Materials stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 35.8%.

Over the past three months, Carpenter Technology's consensus EPS estimate for the current year has increased 2.2%. The stock currently has a Zacks Rank #2 (Buy).

Breaking things down more, Element Solutions is a member of the Chemical - Specialty industry, which includes 44 individual companies and currently sits at #180 in the Zacks Industry Rank. On average, stocks in this group have gained 9.2% this year, meaning that ESI is performing better in terms of year-to-date returns.

Carpenter Technology, however, belongs to the Steel - Speciality industry. Currently, this 6-stock industry is ranked #231. The industry has moved +30.7% so far this year.

Going forward, investors interested in Basic Materials stocks should continue to pay close attention to Element Solutions and Carpenter Technology as they could maintain their solid performance.
2026-06-12 14:18 2mo ago
2026-05-07 18:21 4mo ago
Ensign Energy Services Inc. (ESI:CA) Q1 2026 Earnings Call Transcript
ESI Element Solutions
FMP Stock News
Original source text
Ensign Energy Services Inc. (ESI:CA) Q1 2026 Earnings Call Transcript
2026-06-12 14:18 2mo ago
2026-05-18 20:29 3mo ago
Element Solutions Inc (ESI) Shares Fall 5.8% -- GF Value Says Still Overvalued
ESI Element Solutions
FMP Stock News
Original source text
On May 18, 2026, Element Solutions Inc (ESI) shares fell 5.8% to a current price of $39.88. This decline is notable within the context of its 52-week range, whi
2026-06-12 14:18 2mo ago
2026-05-19 07:30 3mo ago
Element Solutions Inc (ESI) Analyst/Investor Day Transcript
ESI Element Solutions
FMP Stock News
Original source text
Element Solutions Inc (ESI) Analyst/Investor Day Transcript
2026-06-12 14:18 2mo ago
2026-05-20 16:15 3mo ago
Element Solutions Inc Declares Q2 Dividend of $0.08 Per Share
ESI Element Solutions
FMP Stock News
Original source text
MIAMI--(BUSINESS WIRE)--Element Solutions Inc (NYSE: ESI) announced today that its board has declared a quarterly cash dividend of $0.08 per share of the company's common stock. The declared dividend will be paid on June 15, 2026, to stockholders of record as of the close of business on June 1, 2026. About Element Solutions Inc Element Solutions Inc is a leading specialty chemicals technology company whose businesses supply a broad range of solutions that enhance the performance of products peo.
2026-06-12 14:18 2mo ago
2026-05-21 10:40 3mo ago
Is Element Solutions (ESI) Stock Outpacing Its Basic Materials Peers This Year?
ESI Element Solutions
FMP Stock News
Original source text
For those looking to find strong Basic Materials stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Element Solutions (ESI - Free Report) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the rest of the Basic Materials sector should help us answer this question.

Element Solutions is a member of our Basic Materials group, which includes 248 different companies and currently sits at #7 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.

The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. Element Solutions is currently sporting a Zacks Rank of #2 (Buy).

Over the past 90 days, the Zacks Consensus Estimate for ESI's full-year earnings has moved 3% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.

Our latest available data shows that ESI has returned about 62.3% since the start of the calendar year. Meanwhile, the Basic Materials sector has returned an average of 12.7% on a year-to-date basis. This means that Element Solutions is performing better than its sector in terms of year-to-date returns.

One other Basic Materials stock that has outperformed the sector so far this year is Reliance (RS - Free Report) . The stock is up 25.4% year-to-date.

The consensus estimate for Reliance's current year EPS has increased 3.9% over the past three months. The stock currently has a Zacks Rank #2 (Buy).

Breaking things down more, Element Solutions is a member of the Chemical - Specialty industry, which includes 44 individual companies and currently sits at #90 in the Zacks Industry Rank. Stocks in this group have gained about 9.1% so far this year, so ESI is performing better this group in terms of year-to-date returns.

On the other hand, Reliance belongs to the Mining - Miscellaneous industry. This 72-stock industry is currently ranked #162. The industry has moved +22.2% year to date.

Element Solutions and Reliance could continue their solid performance, so investors interested in Basic Materials stocks should continue to pay close attention to these stocks.
2026-06-12 14:18 2mo ago
2026-05-22 09:40 3mo ago
Implied Volatility Surging for Element Solutions Stock Options
ESI Element Solutions
FMP Stock News
Original source text
Investors in Element Solutions Inc (ESI - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the June 18, 2026 $30.00 Call had some of the highest implied volatility of all equity options today.

What is Implied Volatility?Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.

What do the Analysts Think?Clearly, options traders are pricing in a big move for Element Solutions share, but what is the fundamental picture for the company? Currently, Element Solutions is a Zacks Rank #2 (Buy) in the Chemical - Specialty Industry that ranks in the Top 38% of our Zacks Industry Rank. Over the last 60 days, no analyst has increased his estimate for the current quarter, while two have revised their estimates downward. The net effect has taken our Zacks Consensus Estimate for the current quarter to move from 44 cents per share to 43 cents per share in the same time period.

Given the way analysts feel about Element Solutions right now, this huge implied volatility could mean there’s a trade developing. Often times, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.
2026-06-12 14:18 2mo ago
2026-05-28 12:31 3mo ago
Why Is Element Solutions (ESI) Up 0.8% Since Last Earnings Report?
ESI Element Solutions
FMP Stock News
Original source text
A month has gone by since the last earnings report for Element Solutions (ESI - Free Report) . Shares have added about 0.8% in that time frame, underperforming the S&P 500.

Will the recent positive trend continue leading up to its next earnings release, or is Element Solutions due for a pullback? Well, first let's take a quick look at its latest earnings report in order to get a better handle on the recent catalysts for Element Solutions Inc. before we dive into how investors and analysts have reacted as of late.

Element Solutions Tops Earnings and Revenue Estimates in Q1Element Solutions recorded earnings of 23 cents per share for the first quarter of 2026 compared with 40 cents in the year-ago quarter. Reported net income was $56 million, down 43% year over year, primarily due to a gain on the Graphics Solutions divestiture in the prior-year period.  

Barring one-time items, earnings were 41 cents per share, up from 34 cents in the year-ago quarter. The figure beat the Zacks Consensus Estimate of 38 cents. 

The company generated net sales of $840 million, up 41% year over year from $593.7 million. The figure beat the Zacks Consensus Estimate of $744.4 million. Organic net sales rose 10%.  

Element Solutions benefited from strong momentum in its Electronics business, aided by robust demand tied to AI infrastructure, high-performance electronics, advanced packaging and thermal management applications. Acquisitions also contributed to reported growth in the quarter.

Segment HighlightsNet sales in the Electronics segment rose 61% year over year to $633.5 million in the reported quarter. The figure beat the consensus estimate of $532 million. Organic net sales increased 15%. Adjusted EBITDA for the segment increased 34% year over year to $119.1 million.  

In the Specialties segment, net sales increased 4% year over year to $206.5 million. Organic net sales rose 1%. The figure missed the consensus estimate of $207 million. Adjusted EBITDA for the segment rose 9% year over year to $43.2 million.  

Financial PositionElement Solutions ended the quarter with cash and cash equivalents of $177.3 million, down from $626.5 million at the end of 2025. Debt was $2,058.7 million at the end of the quarter compared with $1,625.9 million as of Dec. 31, 2025.  

Cash used in operating activities was $66.6 million against cash provided by operating activities of $26 million in the year-ago quarter. Free cash flow was negative $74.2 million against a positive free cash flow of $30.1 million in the prior-year quarter.  

OutlookThe company now expects full-year 2026 adjusted EBITDA in the range of $665 million to $685 million, up from its earlier outlook of $650 million to $670 million. For the second quarter of 2026, ESI expects adjusted EBITDA between $155 million and $170 million.  

How Have Estimates Been Moving Since Then?Since the earnings release, investors have witnessed a downward trend in estimates review.

VGM ScoresCurrently, Element Solutions has a poor Growth Score of F, a score with the same score on the momentum front. Charting a somewhat similar path, the stock has a score of D on the value side, putting it in the bottom 40% for this investment strategy.

Overall, the stock has an aggregate VGM Score of F. If you aren't focused on one strategy, this score is the one you should be interested in.

OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Interestingly, Element Solutions has a Zacks Rank #2 (Buy). We expect an above average return from the stock in the next few months.
2026-06-12 14:18 2mo ago
2026-06-08 10:41 3mo ago
Are Basic Materials Stocks Lagging Element Solutions (ESI) This Year?
ESI Element Solutions
FMP Stock News
Original source text
Investors interested in Basic Materials stocks should always be looking to find the best-performing companies in the group. Has Element Solutions (ESI - Free Report) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Basic Materials sector should help us answer this question.

Element Solutions is one of 248 individual stocks in the Basic Materials sector. Collectively, these companies sit at #9 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.

The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. Element Solutions is currently sporting a Zacks Rank of #2 (Buy).

Over the past three months, the Zacks Consensus Estimate for ESI's full-year earnings has moved 1.6% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.

Our latest available data shows that ESI has returned about 59.4% since the start of the calendar year. In comparison, Basic Materials companies have returned an average of 10.8%. As we can see, Element Solutions is performing better than its sector in the calendar year.

One other Basic Materials stock that has outperformed the sector so far this year is Metallus (MTUS - Free Report) . The stock is up 14.6% year-to-date.

The consensus estimate for Metallus' current year EPS has increased 1.6% over the past three months. The stock currently has a Zacks Rank #2 (Buy).

Breaking things down more, Element Solutions is a member of the Chemical - Specialty industry, which includes 44 individual companies and currently sits at #109 in the Zacks Industry Rank. This group has gained an average of 10.4% so far this year, so ESI is performing better in this area.

In contrast, Metallus falls under the Steel - Speciality industry. Currently, this industry has 6 stocks and is ranked #167. Since the beginning of the year, the industry has moved +46.9%.

Going forward, investors interested in Basic Materials stocks should continue to pay close attention to Element Solutions and Metallus as they could maintain their solid performance.
2026-06-12 14:18 2mo ago
2026-04-24 09:43 4mo ago
Stock Market Today (LIVE): Meta Plugs Into Amazon's AI Chips; Intel Soars 25% on Earnings
BLD Topbuild
FMP Stock News
Original source text
📌 Top story -- scroll down for more updates

Jobs vs. Cook: Apple’s Two Eras Under the Microscope 5:33 pm

AI is driving the market in multiple directions in 2026, and this week’s winner is Intel (INTC +4.60%). Demand is so high that the company is selling chips it once wrote off as worthless. We discuss the dynamics, then turn to the Jobs/Cook era at Apple (AAPL 1.32%) and yet another SaaSpocalypse.

Travis Hoium, Lou Whiteman, and Jason Moser discuss:

The Jobs/Cook era at Apple Intel and AI SaaSpocalypse 3.0 Value or falling knife? 🎧 The Motley Fool Money podcast drops daily after the bell! Listen on Apple Podcasts, Spotify, or other podcast platforms—or check out the Fool's podcast feed.

Closing Bell 4:03 pm

Intel (INTC +4.60%) is doing the heavy lifting today, surging more than 20% after reporting stronger sales and raising guidance on renewed CPU demand. The Nasdaq is up more than 1.5% on the back of that pop; the S&P 500 is up 0.8%, while the Dow is slightly negative.

Powell cleared, Warsh moves closer: The DOJ dropped its criminal probe of Fed Chair Jerome Powell, removing the main obstacle to Kevin Warsh’s confirmation as his successor,  a key development for monetary policy watchers. Consumer mood hits a record low: April sentiment data came in at its worst level ever, reflecting anxiety over Middle East tensions that have also kept oil prices choppy and weighed on the broader market. SRAD Moves Up Q1 Earnings 3:50 pm — SRAD +3.53%

By David Meier
Team Rule Breakers

Interesting. Just got a note from an earnings and conference call service I use called Quartr (recommend the free version) that said Sportradar Group’s (SRAD 2.71%) management just moved the Q1 2026 earnings report forward from May 6 to April 28. I look forward to hearing what more management has to say about the short reports in addition to the financial results.

ARM Rides Intel’s CPU Wave 2:31 pm — ARM +14.46%

Arm Holdings (ARM +7.87%) surged ~15% Friday after Intel (INTC +4.60%) crushed earnings expectations, driven by explosive data center CPU demand. The catalyst: agentic AI — autonomous systems that plan and act without human input — appears to favor CPUs over GPUs at scale. Intel’s CFO noted that GPU-to-CPU ratios can actually flip in agentic workloads.

The ripple effect: Advanced Micro Devices (AMD +5.09%) jumped 13%+ alongside ARM, as investors bet that the agentic AI buildout lifts all CPU designers. ARM’s edge: Beyond licensing its architecture to Nvidia (NVDA +0.34%) and cloud hyperscalers, ARM debuted its own custom data center chip last month — potentially opening a new direct revenue stream. Charter’s Subscriber Slide Deepens 2:18 pm — CHTR -21.65%

Charter (CHTR +0.82%) stock plunged more than 20% Friday after the cable and broadband company reported Q1 earnings that missed estimates and dialed back its full-year revenue outlook. Revenue fell 1% to $13.6 billion, and EPS of $9.17 missed the $9.96 analyst consensus. CFO Jessica Fischer said average revenue per user could end the year roughly flat — walking back earlier guidance for positive growth.

The subscriber picture: Internet customers declined 120,000 in Q1 — more than double last year’s losses — as fixed wireless and fiber rivals eat into Charter’s core business. Video subscribers also fell, by 60,000. One bright spot: Mobile subscribers grew by 368,000, and Charter said it expects to close its pending Cox merger this summer, pending California regulatory approval. Alphabet's $40 Billion AI Power Play 1:10 pm -- GOOG +1.3%

Alphabet (GOOG +0.64%) is doubling down on the generative AI arms race with a massive commitment to invest up to $40 billion in Anthropic. The deal includes an immediate $10 billion cash injection at a $350 billion valuation, following a similar $25 billion move by Amazon (AMZN 2.00%). Anthropic has become a dominant enterprise force, with its annual run-rate revenue ballooning from $9 billion to over $30 billion in just four months. As the creator of the Claude models hunts for massive computing capacity, this partnership secures Alphabet’s position as a primary infrastructure provider while deepening the integration between Anthropic’s specialized coding models and Google’s global data centers.

Explosive Fiscal Velocity: Anthropic's revenue surged over 230% since late 2025, driven by enterprise adoption of its Claude models for complex software development and reasoning tasks. Infrastructure Synergy: The startup is diversifying its compute needs through high-capacity deals with Broadcom (AVGO 1.05%) and CoreWeave to support its goal of hitting 1 gigawatt of power by year-end. Intel's Back: Data Center Soars, Stock Surges 1:20 pm -- INTC +19.8%

By Tim Green
Team Hidden Gems

★ INTC is recommended in Stock Advisor (Team HG)

CPUs are hot again thanks to agentic AI. Intel (INTC +4.60%) has largely sat out the AI boom so far, but no more. Data center revenue soared 22% in the first quarter, and Intel's guidance blasted past expectations. The CPU industry is supply constrained, so not only is Intel going to ship more server CPUs this year, but pricing should be extremely strong. This is a big reason why the stock surged around 20% on Friday.

The other reason is the foundry. There's not much external revenue yet, but the pieces are falling into place. Yields are improving for the Intel 18A process, and CEO Lip-Bu Tan said he expects commitments from customers for the upcoming Intel 14A process this year. Intel 14A will also be used by Terafab, Elon Musk's semiconductor initiative. The good news keeps piling up for Intel.

The Fear Gauge Is Breaking Its Own Rules 12:35 pm

Wall Street’s "fear gauge," the Cboe Volatility Index (INDEX: VIX), is defying traditional logic by rising alongside the S&P 500. While the two usually move inversely, the VIX remains stubbornly near 20 even as stocks hit record highs. This anomaly suggests investors are aggressively hedging against geopolitical instability and crude oil spikes. Conversely, massive demand for upside call options in leaders like the VanEck Semiconductor ETF (SMH +1.35%) is keeping option premiums — and thus the VIX — inflated. Historically, when volatility and prices climb together for an extended period, it often precedes a near-term market correction as realized volatility "catches up" to the index.

High-Stakes Chip Bets: Bullish sentiment is so high that one trader recently spent $2.4 million on Marvell Technology (MRVL 1.04%) calls, betting the stock will climb another 10% despite already doubling since last month. Skewed Protection: Total call premium in the semiconductor sector now outweighs put premium by 25%, indicating that "fear" in the VIX might actually be a byproduct of FOMO-driven buying rather than pure panic.

TSMC Shares Jump 5% on Rule Change 12:15 pm -- TSM +6.7%

Taiwan Semiconductor Manufacturing Co. (TSM +0.30%) shares surged 5% to a record high Friday following a landmark decision by Taiwan's Financial Supervisory Commission to loosen single-stock investment caps. Domestic funds can now allocate up to 25% of their assets to TSMC, up from the long-standing 10% limit. As the only company holding over a 40% weighting on the Taiwan Stock Exchange, TSMC is the sole beneficiary of this change, which aims to narrow the price gap between local shares and U.S.-listed ADRs. This policy tailwind coincides with explosive 58% profit growth in the first quarter, fueled by relentless demand from AI leader Nvidia (NVDA +0.34%) and Apple (AAPL 1.32%) for cutting-edge processors.

Asia’s Valuation King: TSMC’s record profit — reaching 572.48 billion New Taiwanese dollars — marks its fourth consecutive quarter of peak earnings as AI infrastructure spending shows no sign of cooling. Passive Inflow Catalyst: With Taiwan’s benchmark index now the seventh-largest globally, the expanded 25% cap allows local actively managed ETFs to chase the semiconductor boom without the previous regulatory "handcuffs." Is Nvidia Losing Its Grip on China? 11:20 am -- NIO -1.0%

NIO (NIO 0.19%) is pivoting toward in-house semiconductor development to erode its dependence on Nvidia (NVDA +0.34%) and bolster long-term profitability. CEO William Li stated Friday that custom silicon better aligns with the company's proprietary algorithms for advanced driver-assistance systems compared to off-the-shelf hardware. While research costs are substantial, Li argues that avoiding Nvidia’s "high gross margins" will eventually lift the automaker's bottom line. The strategy centers on the newly independent Shenji chip unit and a native operating system, which NIO believes are vital to redefining the global luxury electric vehicle market and securing a competitive edge against both domestic rivals and Western incumbents.

Open-Market Ambitions: By spinning off the Shenji unit, NIO intends to supply its high-performance automotive chips to external manufacturers, potentially creating a secondary revenue stream. Algorithm Synergy: Specialized nanometer-scale chips allow for a tighter integration with NIO’s sensor layouts, reducing the latency and power consumption typical of general-purpose AI processors. The Fear Gauge Is Breaking Its Own Rules 12:35 pm

Wall Street’s "fear gauge," the Cboe Volatility Index (INDEX: VIX), is defying traditional logic by rising alongside the S&P 500. While the two usually move inversely, the VIX remains stubbornly near 20 even as stocks hit record highs. This anomaly suggests investors are aggressively hedging against geopolitical instability and crude oil spikes. Conversely, massive demand for upside call options in leaders like the VanEck Semiconductor ETF (SMH +1.35%) is keeping option premiums — and thus the VIX — inflated. Historically, when volatility and prices climb together for an extended period, it often precedes a near-term market correction as realized volatility "catches up" to the index.

High-Stakes Chip Bets: Bullish sentiment is so high that one trader recently spent $2.4 million on Marvell Technology (MRVL 1.04%) calls, betting the stock will climb another 10% despite already doubling since last month. Skewed Protection: Total call premium in the semiconductor sector now outweighs put premium by 25%, indicating that "fear" in the VIX might actually be a byproduct of FOMO-driven buying rather than pure panic.

Is Nvidia Losing Its Grip on China? 11:20 am -- NIO -1.0%

NIO (NIO 0.19%) is pivoting toward in-house semiconductor development to erode its dependence on Nvidia (NVDA +0.34%) and bolster long-term profitability. CEO William Li stated Friday that custom silicon better aligns with the company's proprietary algorithms for advanced driver-assistance systems compared to off-the-shelf hardware. While research costs are substantial, Li argues that avoiding Nvidia’s "high gross margins" will eventually lift the automaker's bottom line. The strategy centers on the newly independent Shenji chip unit and a native operating system, which NIO believes are vital to redefining the global luxury electric vehicle market and securing a competitive edge against both domestic rivals and Western incumbents.

Open-Market Ambitions: By spinning off the Shenji unit, NIO intends to supply its high-performance automotive chips to external manufacturers, potentially creating a secondary revenue stream. Algorithm Synergy: Specialized nanometer-scale chips allow for a tighter integration with NIO’s sensor layouts, reducing the latency and power consumption typical of general-purpose AI processors. AMD Hits Record High on AI Pivot 10:15 am -- AMD +13.9%

Advanced Micro Devices (AMD +5.09%) shares surged 10% to all-time highs Friday following a bullish upgrade from D.A. Davidson. The shift from Neutral to Buy comes as rival Intel (INTC +4.60%) reported explosive results, signaling a "CPU renaissance" where general-purpose processors are becoming the bedrock for AI agents. Analysts suggest that as "agentic" workloads move beyond specialized GPUs, AMD’s CPU franchise is poised for a massive expansion. With the market pivoting toward more versatile compute needs, AMD is capturing record-breaking momentum, proving that the AI era isn't solely reserved for graphics chips.

Bot-Driven Demand: The rise of autonomous AI agents is shifting technical requirements, favoring the high-throughput reasoning capabilities found in the latest Zen architecture. Symbiotic Rally: Intel's optimistic forecast acted as a sector-wide catalyst, convincing institutional investors that the broader semiconductor cycle is entering a new, durable growth phase.

Today's Change

(

5.09

%) $

24.85

Current Price

$

513.30

Meta Strikes Massive Chip Deal With AWS 10:05 am -- META +0.8%

Meta (META 0.68%) is deepening its infrastructure splurge, inkng a three-year deal to deploy hundreds of thousands of Amazon (AMZN 2.00%) Web Services Graviton chips. This agreement follows $48 billion in recent commitments to Nebius (NBIS +6.54%) and CoreWeave for Nvidia (NVDA +0.34%) hardware. By adopting these Arm-based (ARM +7.87%) processors, Meta aims to optimize "agentic AI" and post-training refinements with 60% better energy efficiency than traditional setups. While CEO Mark Zuckerberg counterbalances this spend with a fresh 10% workforce reduction, the pivot to custom silicon highlights a desperate race to secure compute capacity as competitors like Alphabet (GOOG +0.64%) and Microsoft (MSFT 1.65%) scale their own internal hardware.

The CPU Renaissance: Intel (INTC +4.60%) leadership recently noted that central processors are re-emerging as the "indispensable foundation" for AI, as seen by Meta selecting Graviton over specialized accelerators for intensive agent workloads. Economic Trade-off: Meta’s massive infrastructure investment coincides with 8,000 fresh layoffs, signaling a permanent shift in capital allocation from human headcount to high-performance silicon.

Today's Change

(

-0.68

%) $

-3.86

Current Price

$

564.57

Top of the Morning 9:45 am -- LUV +2.2%

By Alicia Alfiere
Team Rule Breakers

Southwest (LUV 0.02%) built its brand on being a low-cost carrier, also known as an LCC in the airlines biz. But now, the company is undergoing a massive transformation to make it ... well, like most other airlines.

In January, the airline began a new practice of offering assigned seating and extra legroom. That's not a small change -- it caused the airline to retrofit aircraft to accommodate its strategy shift. The company also signed strategic partnerships with other airlines. That's important because it allows customers to book longer, international trips with Southwest flying part of the route. And, it means customers can earn and use miles for flights on more than just Southwest. That's kind of a big deal for business fliers and certain leisure travelers too.

6:45 am

By Morning Show host Jim Mueller, CFA
Team Rule Breakers

Have you run into the prediction markets recently?

If you’ve tried to log into your broker, it’s quite possible. I know as I log into my Interactive Broker account, I see a chance to make an "investment" on some prediction. Will the Fed raise interest rates at its next meeting? Yes or No?

I say "yes" (just for example) and put some money on the line. Maybe $0.60 for a single contract. If I’m right and the Fed does raise interest rates, I’ll make $0.40 as I get my investment back plus the cost paid from someone saying the opposite who lost (less a fee paid to the provider of that market).

The price I pay depends on how many others of the total are saying the same thing. The more people who say "yes", the more expensive the investment becomes and the less the return is if you’re right. That’s how the odds are set. The companies offering this stand to make a lot of money. Recently, Kalshi and Polymarket together handled over $5 billion in weekly prediction market investments recently. Say they take a 2% cut. That’s $100 million in a week. There’s a lot of money involved.

Yet, this isn’t gambling. It’s a futures market. At least according to a recent ruling by a federal appeals court in New Jersey. And that has huge implications. If it holds, this kind of thing will be legal in all 50 states and the District of Columbia.

There are some troublesome aspects about this, though.

4:00 am — MEDP -0.75% in pre-market trading

By Morning Show host Jim Gillies

When Medpace Holdings (MEDP 0.65%) reported Q1-26 results after market close on Wednesday I knew that my topic for today was going to be discussing earnings. Let's get to the results first before discussing some implications.

Results? Actually pretty good.

Revenue was up 26.5% year-over-year, EBITDA up 25.9%, and Net income up 8.1%. That last one might seem disappointing, but last year saw an ultra-low effective tax rate (3%) while this year returned to a more normal level (upper teens). Despite those tax rate "variabilities", earnings per share (EPS) were up 16.4% year-over-year, mainly because of the aggressive share buybacks Medpace did between Q4-24 and Q2-25 that shrank share count by 7.2% year-over-year. Also working against EPS growth pacing revenue growth is that revenue attributable to "reimbursed pass-through expenses" was elevated versus last year as expected. This quarter 44.2% of revenue was "reimbursed costs" versus 36.2% last year. Free cash flow of $145 million was up 25% versus last year, the cash pile on the debt-free balance sheet reaching nearly $653 million. New business awards were up nearly 24% year-over-year to $618.4 million. Management reaffirmed full-year guidance. So – that all looks pretty great, why then did the stock price get obliterated by as much as 27% yesterday?

I believe the answer can be found on two fronts. First, and of the most importance is the "book-to-bill" ratio – new business awards divided by reported revenue. All else equal a book-to-bill above 1.0 foreshadows future growth and is greeted with much rejoicing by the market. A book-to-bill below 1.0 heralds future (near-term) revenue decline.

Opening Bell 9:35 am -- INTC +25.0%

The S&P 500 edged higher Friday as optimism regarding imminent U.S.-Iran negotiations in Pakistan countered a week of broad market declines. While geopolitical tension persists in the Strait of Hormuz, investors are refocusing on a stellar semiconductor sector. Intel (INTC +4.60%) shares surged 24% after a dominant first-quarter beat and optimistic guidance, fueling a record-breaking 17-day winning streak for the iShares Semiconductor ETF (SOXX +1.41%). Despite the tech boost, the Dow remains on track for a losing week as traders weigh "super normal" chip growth against the risks of a naval standoff.

Crude Volatility Cooling: Oil prices retreated as West Texas Intermediate dipped toward $95 per barrel, signaling that energy markets are pricing in a potential diplomatic breakthrough in Islamabad. Narrowing Market Leadership: NewEdge Wealth analysts warn that the rally is becoming dangerously reliant on cyclical semiconductors, which are projected to deliver 100% earnings growth this year. Market indexes

S&P 500

0.23%

Nasdaq

0.67%

Dow

-0.32%

Which Eggs Should Go in Which Baskets 8:00 am

By Robert Brokamp, CFP®
Team Hidden Gems

In his 1605 novel Don Quixote, Cervantes wrote, "It is the part of a wise man to keep himself today for tomorrow, and not to venture all his eggs in one basket."

More than four centuries later, the phrase is still used to represent the value of diversification: Don't put all your money in one investment or type of investment.

A modern spin on the phrase could go this way: Buy all kinds of eggs (investments) and have a few different types of baskets (accounts).

We at the Fool have recommended that investors own at least 25 stocks, and co-founder and CEO Tom Gardner recently increased that number to 50. Personally, I believe a diversified portfolio of low-cost index funds is also a good diversifying complement to a portfolio of individual stocks.

Deciding which investments to own is crucial. But another important consideration is in which types of accounts to own them.

This Morning's Breakfast News 7:30 am -- INTC +26.67% in pre-market trading

Intel (INTC +4.60%) soared 25% ahead of the market open after CEO Lip-Bu Tan praised the Team Hidden Gems recommendation's ongoing pivot to AI, saying "this is a fundamentally different company today," with results beating expectations and the financial outlook upgraded.

"Focused on maximizing our factory network to improve available supply and meet our customers' needs": CFO David Zinsner explained high demand in areas such as data center processors means Intel is striving to quickly increase capacity to avoid disappointment. "The backbone of AI computing in production remains a CPU anchored architecture": CEO Tan flagged "great news for Intel" for the future as more companies are deploying Intel's CPUs as AI systems become more complex. This is one factor contributing to increasing next quarter's revenue guidance from $13 billion to between $13.8 billion and $14.8 billion.

Rocket Lab Unveils Deep-Space Star Tracker 6:00 am -- RKLB +1.30% in pre-market trading

Rocket Lab (RKLB 8.34%) is doubling down on its vertical integration strategy, unveiling a next-generation High-Performance Star Tracker (ST-HP) designed for extreme deep-space environments. The new sensor achieves pointing accuracy better than 1 arcsecond and features radiation hardening capable of withstanding 50 kRad, making it ideal for the long-duration missions increasingly demanded by defense and commercial constellations. The launch follows a "rapid-fire" week for the company, which saw its stock climb over 30% in April to roughly $85.70 after completing back-to-back missions for JAXA and closing its $155 million acquisition of laser-comms firm Mynaric.

The Margin Multiplier: By manufacturing the ST-HP in-house alongside its reaction wheels and flight software, Rocket Lab aims to capture more "satellite real estate" and improve margins compared to pure-play launch rivals. Operational Velocity: The announcement coincided with the company's eighth successful launch of 2026, keeping it on track for 20% year-over-year growth as it prepares for the debut of its larger Neutron rocket.

Today's Change

(

-8.34

%) $

-9.57

Current Price

$

105.21

ICYMI: Thursday's Scoreboard 5:15 am -- BLD unchanged in pre-market trading

TopBuild (BLD +0.48%) was the subject of the latest Scoreboard video.

Before the Opening Bell 5:00 am

Stock futures showed mixed momentum Friday after President Trump announced a three-week extension of the Israel-Lebanon ceasefire, providing a rare pocket of stability as the U.S.-Iran standoff continues. While the regional peace progress offered hope for stalled negotiations, the tech sector remained the primary engine for gains. Intel (INTC +4.60%) shares climbed after the chipmaker delivered its sixth consecutive earnings beat, with CEO Lip-Bu Tan highlighting a massive surge in demand for AI-centric CPUs. The upbeat mood followed a historic rally in Texas Instruments (TXN +1.14%), which saw its biggest jump in 25 years after crushing estimates, signaling that the "AI trade" is finally lifting legacy semiconductor names.

Foundry and AI Focus: Intel's Q1 revenue reached $13.6 billion, outperforming its own guidance by $1.4 billion as it scales "agentic AI" infrastructure to meet unprecedented silicon demand. Blue-Chip Friday: Investors are now parsing pre-market results from Procter & Gamble (PG +0.44%), which expects a volume recovery in beauty and home care, alongside healthcare giant HCA Healthcare (HCA +0.91%) and Norfolk Southern (NSC +0.66%). Cannabis Stocks Slide Post-DOJ Order 4:30 am -- TLRY -0.88%, CGC +0.82% in pre-market trading

The U.S. Department of Justice has officially reclassified cannabis to a less dangerous drug, a major shift in the country's policy and a move that saw sharp volatility in related stocks including Tilray Brands (TLRY 1.76%) and Canopy Growth (CGC +0.49%).

The move doesn't legalise cannabis at a federal level: Cannabis will now be obtainable with a prescription, providing a boost for the $47 billion industry as access to funding and other benefits become obtainable, with more legal progress likely further down the line. Sector reaction is telling: After initially spiking on the news, marijuana stocks closed Thursday lower, with Tilray and Canopy Growth down over 11%, with a mix of "buy-the-rumor, sell-the-news" action, along with a realization of a lengthy regulatory road still ahead.

Today's Change

(

-1.76

%) $

-0.09

Current Price

$

5.03
2026-06-12 14:18 2mo ago
2026-04-24 12:13 4mo ago
Why QXO Stock Dropped This Week, and Why I'm Holding My Shares
BLD Topbuild
FMP Stock News
Original source text
QXO (QXO +0.54%) did exactly what investors expected this week. The building products distribution company started by entrepreneur Brad Jacobs announced another acquisition.

Investors may wonder why QXO stock was down about 14% for the week as of Friday afternoon, according to data provided by S&P Global Market Intelligence. The company just announced its third major acquisition, and second this year. Here's what some investors might be wary about.

Image source: The Motley Fool.

Bet on the jockey QXO announced this week that it was buying TopBuild Corp (BLD +0.48%). for about $17 billion. TopBuild is the leading distributor and installer of insulation and related construction products in North America. QXO has already closed acquisitions of Beacon Roofing Supply and Kodiak Building Partners in the last year, totaling about $13.25 billion.

QXO was founded by Brad Jacobs with the goal of consolidating the $800 billion building products distribution industry and leveraging technology to enhance efficiency. Jacobs was also the founder of other successful businesses, including the transportation and logistics company XPO Logistics and equipment rental company United Rentals.

Today's Change

(

0.54

%) $

0.09

Current Price

$

16.67

QXO stock was always a bet on Jacobs. While the $17 billion price tag for TopBuild may be scaring some investors away, Jacobs hasn't altered his vision for QXO. The latest combination is also expected to immediately and materially boost QXO's earnings. Those positive results would be even stronger if the construction and housing markets strengthen. That's why I'm holding onto my QXO shares.

Howard Smith has positions in QXO. The Motley Fool has positions in and recommends QXO and TopBuild. The Motley Fool recommends XPO. The Motley Fool has a disclosure policy.
2026-06-12 14:18 2mo ago
2026-04-26 03:11 4mo ago
AEGON ASSET MANAGEMENT UK Plc Sells 11,813 Shares of TopBuild Corp. $BLD
BLD Topbuild
FMP Stock News
Original source text
Posted by Defense World Staff on Apr 26th, 2026

AEGON ASSET MANAGEMENT UK Plc trimmed its holdings in shares of TopBuild Corp. (NYSE:BLD – Free Report) by 12.6% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 82,057 shares of the construction company’s stock after selling 11,813 shares during the period. AEGON ASSET MANAGEMENT UK Plc owned approximately 0.29% of TopBuild worth $34,233,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Inscription Capital LLC lifted its position in TopBuild by 104.6% during the third quarter. Inscription Capital LLC now owns 2,949 shares of the construction company’s stock valued at $1,153,000 after purchasing an additional 1,508 shares in the last quarter. Calamos Advisors LLC purchased a new position in TopBuild during the third quarter valued at $997,000. WCM Investment Management LLC purchased a new position in TopBuild during the third quarter valued at $17,734,000. Campbell & CO Investment Adviser LLC lifted its position in TopBuild by 697.8% during the third quarter. Campbell & CO Investment Adviser LLC now owns 7,906 shares of the construction company’s stock valued at $3,090,000 after purchasing an additional 6,915 shares in the last quarter. Finally, Citigroup Inc. lifted its position in TopBuild by 20.7% during the third quarter. Citigroup Inc. now owns 34,992 shares of the construction company’s stock valued at $13,677,000 after purchasing an additional 5,991 shares in the last quarter. 95.67% of the stock is owned by institutional investors.

Analyst Ratings Changes Several equities analysts recently weighed in on BLD shares. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $496.00 target price (up from $487.00) on shares of TopBuild in a research report on Tuesday, April 21st. DA Davidson reiterated a “buy” rating and set a $465.00 target price on shares of TopBuild in a research report on Monday, April 20th. Seaport Research Partners reiterated a “neutral” rating on shares of TopBuild in a research report on Tuesday, April 7th. Weiss Ratings downgraded TopBuild from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Friday, February 27th. Finally, Wells Fargo & Company lowered their price objective on TopBuild from $525.00 to $475.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 8th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $447.21.

View Our Latest Analysis on BLD

TopBuild Trading Down 2.5% Shares of BLD stock opened at $453.79 on Friday. TopBuild Corp. has a 12-month low of $273.87 and a 12-month high of $559.47. The company has a current ratio of 1.94, a quick ratio of 1.34 and a debt-to-equity ratio of 1.21. The stock’s 50-day moving average price is $411.15 and its 200-day moving average price is $436.39. The stock has a market capitalization of $12.77 billion, a price-to-earnings ratio of 24.80, a price-to-earnings-growth ratio of 5.84 and a beta of 1.78.

TopBuild (NYSE:BLD – Get Free Report) last issued its earnings results on Thursday, February 26th. The construction company reported $4.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.39 by $0.11. TopBuild had a return on equity of 25.66% and a net margin of 9.65%.The firm had revenue of $1.50 billion for the quarter, compared to analysts’ expectations of $1.49 billion. During the same period in the previous year, the firm posted $5.13 earnings per share. The business’s revenue was up 13.2% compared to the same quarter last year. Equities research analysts predict that TopBuild Corp. will post 18.12 EPS for the current fiscal year.

TopBuild Profile (Free Report)

TopBuild Corp. (NYSE: BLD) is a leading installer and distributor of insulation and building material products serving primarily the U.S. construction market. Headquartered in Daytona Beach, Florida, the company was formed in 2011 as a spin-off from ABF Freight System and has since grown through a combination of organic expansion and targeted acquisitions. TopBuild’s core mission is to enhance energy efficiency and comfort in new residential and light commercial construction projects by providing comprehensive insulation solutions and related services.

The company operates through two main segments.

Further Reading Five stocks we like better than TopBuild Want to see what other hedge funds are holding BLD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TopBuild Corp. (NYSE:BLD – Free Report).

Receive News & Ratings for TopBuild Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TopBuild and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAdvisors Capital Management LLC Buys 3,996 Shares of Agnico Eagle Mines Limited $AEM

NEXT HEADLINE »AEGON ASSET MANAGEMENT UK Plc Sells 14,752 Shares of Moody’s Corporation $MCO
2026-06-12 14:18 2mo ago
2026-05-05 06:45 4mo ago
TopBuild Reports First Quarter 2026 Results
BLD Topbuild
FMP Stock News
Original source text
DAYTONA BEACH, Fla., May 05, 2026 (GLOBE NEWSWIRE) -- TopBuild Corp. (NYSE:BLD), a leading installer of insulation and commercial roofing and a specialty distributor of insulation and related building products to the construction industry in the United States and Canada, today reported results for the first quarter ended March 31, 2026.

“Our first quarter performance was in line with our expectations as we continue our focus on delivering compounding shareholder returns, driving operational excellence, and executing our long-term strategy,” said Robert Buck, CEO of TopBuild.

“In the first quarter, sales grew 17.2%, driven by the 2025 acquisitions of SPI and Progressive Roofing, offsetting the macro challenges in residential and light commercial new construction. While the residential market faces ongoing uncertainty, the heavy commercial and industrial end markets are healthy and our results are solid. We are also making excellent progress on the SPI integration and are on track to meet or exceed our original synergy targets,” Mr. Buck continued.

“M&A continues to be a priority given our strong free cash flow and robust pipeline of acquisitions across our installation and specialty distribution segments. To date in 2026, we’re pleased to have completed four acquisitions which together add more than $80 million in annual revenue, further diversify our end-market exposure and continue to position us for long-term growth.

“We are excited about our future in joining QXO, as was announced on April 19. By combining the TopBuild business with QXO, we are confident in our opportunities to accelerate our cross-selling initiatives, capitalize on procurement opportunities and leverage digital technology in a manner that will benefit our customers, employees and all stakeholders,” Mr. Buck concluded.

Financial Highlights
(comparisons are to the three months ended March 31, 2025)

         Reported Adjusted ($ in thousands) 2026  2025   2026  2025  Sales$1,445,860 $1,233,278  $1,445,860 $1,233,278  Gross Profit$400,253 $351,473  $400,273 $364,976  Gross Margin 27.7% 28.5%  27.7% 29.6% SG&A$225,210 $173,984  $222,578 $170,829  SG&A as % of Sales 15.6% 14.1%  15.4% 13.9% Operating Profit$175,043 $177,489  $177,695 $194,147  Operating Margin 12.1% 14.4%  12.3% 15.7% Net Income$104,813 $123,385  $105,375 $135,147  Net Income per diluted share$3.73 $4.23  $3.75 $4.63  EBITDA   $238,619 $234,759  EBITDA Margin    16.5% 19.0%        Sales Drivers
(comparisons are to the three months ended March 31, 2025)

         Three Months Ended March 31, 2026  Installation
Services
  Specialty
Distribution
  TopBuild,
net of 
eliminations
 Sales (in millions) $777  $737  $1,446 Sales Drivers      Volume  (9.8%)  0.3%  (5.5%)Price  (2.9%)  0.3%  (1.6%)M&A  16.9%  31.1%  24.3%Total Sales Change  4.3%  31.7%  17.2%        Segment Profitability        
(comparisons are to the three months ended March 31, 2025)

    Three Months Ended March 31, 2026($ in thousands)Installation
ServicesSpecialty DistributionOperating Profit$119,191 $80,008 Change (8.0%) 15.9%Operating Margin 15.3% 10.9%Adj. Operating Profit$119,549 $80,265 Change (13.4%) 5.7%Adj. Operating Margin 15.4% 10.9%Adj. EBITDA$149,168 $106,528 Change (5.3%) 16.6%Adj. EBITDA Margin 19.2% 14.5%    Capital Allocation
2026 Acquisitions

CompanyAnnual Revenue Month Closed($ in millions) Upstate Spray Foam Insulation and Applied Coatings (I)$19.6 FebruaryJohnson Roofing (I) 29.2 AprilEnergy Pros (I) 4.0 MayClaremont (D) 31.0 MayTotal$ 83.8  I = Installation Services, D = Specialty Distribution        In addition to the acquisitions completed as listed above, TopBuild has signed a definitive agreement to acquire Comfort Pro, an insulation installation company based in Little Suamico, Wisc. with approximately $6 million in annual sales. The transaction is expected to close in the second quarter.

About TopBuild

TopBuild Corp., headquartered in Daytona Beach, Florida, is a leading installer of insulation and commercial roofing and is also a specialty distributor of insulation and related building products to the construction industry in the United States and Canada. We provide insulation and commercial roofing installation services nationwide through our Installation Services segment which has over 200 branches located across the United States. We distribute building and mechanical insulation, insulation accessories, and other building products for the residential, commercial, and industrial end markets through our Specialty Distribution business. Our Specialty Distribution network encompasses more than 250 branches across the United States and Canada. To learn more about TopBuild please visit our website at www.topbuild.com.

Use of Non-GAAP Financial Measures

Adjusted EBITDA, incremental EBITDA margin, adjusted EBITDA margin, the “adjusted” financial measures presented above, and figures presented on a “same branch basis” are not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). The Company believes that these non-GAAP financial measures, which are used in managing the business, may provide users of this financial information with additional meaningful comparisons between current results and results in prior periods. We define same branch sales as sales from branches in operation for at least 12 full calendar months. Such non-GAAP financial measures are reconciled to their closest GAAP financial measures in tables contained in this press release. Non-GAAP financial measures should be viewed in addition to, and not as an alternative for, the Company’s reported results under GAAP. Additional information may be found in the Company’s filings with the Securities and Exchange Commission which are available on TopBuild’s website under “SEC Filings” at www.topbuild.com.

Safe Harbor Statement

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act. These forward-looking statements may address, among other things, our expected financial and operational results, the related assumptions underlying our expected results, and our plan to repurchase our common stock under stock repurchase transactions. These forward-looking statements can be identified by words such as “will,” “would,” “anticipate,” “expect,” “believe,” “designed,” “plan,” “may,” “project,” “estimate” or “intend,” the negative of these terms, and similar references to future periods. These views involve risks and uncertainties that are difficult to predict and, accordingly, our actual results may differ materially from the results discussed in our forward-looking statements. Our forward-looking statements contained herein speak only as of the date of this press release. Factors or events that we cannot predict, including those described in the risk factors contained in our filings with the Securities and Exchange Commission, may cause our actual results to differ from those expressed in forward-looking statements. Although TopBuild believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, the Company can give no assurance that its expectations will be achieved and it undertakes no obligation to update any forward-looking statements as a result of new information, future events, or otherwise, except as required by applicable law.

(tables follow)

TopBuild Corp.      Condensed Consolidated Statements of Operations (Unaudited)    (in thousands, except share and per common share amounts)               Three Months Ended March 31,   2026  2025 Net sales $1,445,860     $1,233,278 Cost of sales  1,045,607   881,805 Gross profit  400,253   351,473        Selling, general, and administrative expense  225,210   173,984 Operating profit  175,043   177,489        Other income (expense), net:      Interest expense  (36,623)  (16,602)Other, net  1,327   5,086 Other expense, net  (35,296)  (11,516)Income before income taxes  139,747   165,973        Income tax expense  (34,934)  (42,588)Net income $104,813  $123,385        Net income per common share:      Basic $3.75  $4.25 Diluted $3.73  $4.23        Weighted average shares outstanding:      Basic  27,976,514   29,028,234 Diluted  28,130,208   29,174,892         TopBuild Corp.      Condensed Consolidated Statements of Comprehensive Income (Unaudited)   (in thousands)               Three Months Ended March 31,   2026  2025Net income $104,813  $123,385Other comprehensive (loss) income:      Foreign currency translation adjustment  (4,342)  229Comprehensive income $100,471  $123,614        TopBuild Corp.       Condensed Consolidated Balance Sheets and Other Financial Data (Unaudited)       (dollars in thousands)         As of   March 31,  December 31,    2026 2025 ASSETS       Current assets:       Cash and cash equivalents $268,847 $184,742 Receivables, net of an allowance for credit losses of $29,680 at March 31, 2026, and $29,081 at December 31, 2025  930,521  894,408 Inventories  515,143  505,167 Prepaid expenses and other current assets  42,148  50,478 Total current assets  1,756,659  1,634,795         Right of use assets  261,536  271,396 Property and equipment, net  286,525  291,556 Goodwill  3,070,940  3,045,227 Other intangible assets, net  1,325,038  1,351,612 Other assets  10,465  10,726 Total assets $6,711,163 $6,605,312         LIABILITIES       Current liabilities:       Accounts payable $471,217 $440,214 Current portion of long-term debt  62,500  62,500 Accrued liabilities  251,991  249,361 Short-term operating lease liabilities  87,302  86,170 Short-term finance lease liabilities  6,611  6,571 Total current liabilities  879,621  844,816         Long-term debt  2,769,888  2,784,197 Deferred tax liabilities, net  395,765  387,594 Long-term portion of insurance reserves  58,645  58,681 Long-term operating lease liabilities  190,086  200,729 Long-term finance lease liabilities  11,014  11,020 Other liabilities  1,782  2,115 Total liabilities  4,306,801  4,289,152         EQUITY  2,404,362  2,316,160 Total liabilities and equity $6,711,163 $6,605,312           As of March 31,    2026 2025 Other Financial Data       Receivables, net plus inventories less accounts payable $974,447 $731,997 Net sales, acquisition adjusted † $6,154,730 $5,329,105 Receivables, net plus inventories less accounts payable as a percent of sales (TTM) †  15.8% 13.7%        † Trailing 12 months sales have been adjusted for the pro forma effect of acquired branches                TopBuild Corp.      Condensed Consolidated Statement of Cash Flows (Unaudited)      (in thousands)               Three Months Ended March 31,   2026  2025 Cash Flows Provided by (Used in) Operating Activities:           Net income $104,813  $123,385 Adjustments to reconcile net income to net cash provided by operating activities:      Depreciation and amortization  56,295   35,791 Share-based compensation  4,629   5,042 Loss on sale of assets  327   829 Amortization of debt issuance costs  1,216   720 Provision for bad debt expense  3,412   3,666 Provision for inventory obsolescence  2,284   2,820 Impairment losses  —   9,868 Deferred income taxes, net  (20)  (1,822)Change in certain assets and liabilities, net of effects of businesses acquired:      Receivables, net  (38,542)  (1,118)Inventories  (18,336)  (2,215)Prepaid expenses and other current assets  8,198   9,646 Accounts payable  31,464   (32,342)Accrued liabilities  4,739   (1,050)Other, net  257   (631)Net cash provided by operating activities  160,736   152,589        Cash Flows Provided by (Used in) Investing Activities:      Purchases of property and equipment  (13,999)  (13,395)Acquisition of businesses, net of cash acquired  (27,888)  294 Proceeds from sale of assets  394   248 Net cash used in investing activities  (41,493)  (12,853)       Cash Flows Provided by (Used in) Financing Activities:      Repayment of long-term debt  (15,625)  (11,250)Proceeds from revolving credit facility  65,000   — Repayment of revolving credit facility  (65,000)  — Principal payments on finance lease obligations  (1,861)  — Taxes withheld and paid on employees' equity awards  (18,293)  (4,466)Exercise of stock options  1,394   — Repurchase of shares of common stock  —   (215,628)Net cash used in financing activities  (34,385)  (231,344)Impact of exchange rate changes on cash  (753)  101 Net increase (decrease) in cash and cash equivalents  84,105   (91,507)Cash and cash equivalents - Beginning of period  184,742   400,318 Cash and cash equivalents - End of period $268,847  $308,811        Supplemental disclosure of noncash activities:      Leased assets obtained in exchange for new operating lease liabilities $12,987  $17,547 Leased assets obtained in exchange for new finance lease liabilities  1,831   — Accruals for property and equipment  685   444 Excise taxes capitalized to treasury stock  —   2,156         TopBuild Corp.         Segment Data (Unaudited)         (dollars in thousands)                     Three Months Ended March 31,       2026  2025 ChangeInstallation Services         Sales $777,329 $745,533  4.3%          Operating profit, as reported $119,191 $129,616   Operating margin, as reported  15.3% 17.4%            Rationalization charges  —  8,281   Acquisition related costs  358  143   Operating profit, as adjusted $119,549 $138,040   Operating margin, as adjusted  15.4% 18.5%            Share-based compensation  428  349   Depreciation and amortization  29,191  19,167   EBITDA, as adjusted $149,168 $157,556  (5.3)%EBITDA margin, as adjusted  19.2% 21.1%            Specialty Distribution         Sales $737,080 $559,804  31.7%          Operating profit, as reported $80,008 $69,059   Operating margin, as reported  10.9% 12.3%            Rationalization charges  —  6,868   Acquisition related costs  257  37   Operating profit, as adjusted $80,265 $75,964   Operating margin, as adjusted  10.9% 13.6%            Share-based compensation  843  463   Depreciation and amortization  25,420  14,939   EBITDA, as adjusted $106,528 $91,366  16.6%EBITDA margin, as adjusted  14.5% 16.3%             TopBuild Corp.         Adjusted EBITDA (Unaudited)         (dollars in thousands)                     Three Months Ended March 31,      2026   2025 Change  Total net sales         Sales before eliminations $1,514,409  $1,305,337    Intercompany eliminations  (68,549)  (72,059)   Net sales after eliminations $1,445,860  $1,233,278  17.2%          Operating profit, as reported - segments $199,199  $198,675    General corporate expense, net  (10,674)  (9,259)   Intercompany eliminations  (13,482)  (11,927)   Operating profit, as reported $175,043  $177,489    Operating margin, as reported  12.1%  14.4%             Rationalization charges  —   15,358    Acquisition related costs †  2,652   1,300    Operating profit, as adjusted $177,695  $194,147    Operating margin, as adjusted  12.3%  15.7%             Share-based compensation  4,629   5,042    Depreciation and amortization  56,295   35,570    EBITDA, as adjusted $238,619  $234,759  1.6%EBITDA margin, as adjusted  16.5%  19.0%             Sales change period over period  212,582       EBITDA, as adjusted, change period over period  3,860       Incremental EBITDA, as adjusted, as a percentage of change in sales  1.8%                          † Acquisition related costs include corporate level adjustments as well as segment operating adjustments.                 TopBuild Corp.      Same Branch and Acquisition Metrics (Unaudited)      (dollars in thousands)               Three Months Ended March 31,   2026  2025 Net sales      Same branch:      Installation Services $651,097  $745,533 Specialty Distribution  562,934   559,804 Eliminations  (68,315)  (72,059)Total same branch $1,145,716  $1,233,278        Acquisitions (a):      Installation Services $126,232  $— Specialty Distribution  174,146   — Eliminations  (234)  — Total acquisitions  300,144   — Total net sales $1,445,860  $1,233,278        EBITDA, as adjusted      Same branch:      Installation Services $126,695  $157,557 Specialty Distribution  86,071   91,367 Eliminations  (17,077)  (14,165)Total same branch $195,689  $234,759        Acquisitions (a):      Installation Services $22,473  $— Specialty Distribution  20,457   — Total acquisitions  42,930   — Total EBITDA, as adjusted $238,619  $234,759        EBITDA, as adjusted, as a percentage of sales      Same branch (b)  17.1%   Acquisitions (c)  14.3%   Total (d)  16.5%  19.0        As Adjusted (Decremental)/Incremental EBITDA, as a percentage of change in sales      Same branch (e)  (44.6)%   Acquisitions (c)  14.3%   Total (f)  1.8%          (a) Represents current year impact of acquisitions in their first twelve months      (b) Same branch metric, as adjusted, as a percentage of same branch sales      (c) Acquired metric, as adjusted, as a percentage of acquired sales      (d) Total EBITDA, as adjusted, as a percentage of total sales      (e) Change in same branch EBITDA, as adjusted, as a percentage of change in same branch sales      (f) Change in total EBITDA, as adjusted, as a percentage of change in total sales              TopBuild Corp.         Same Branch Revenue by Line of Business (Unaudited)      (dollars in thousands)                     Three Months Ended March 31,      2026 2025 ChangeResidential:         Same branch $685,972 $769,751  (10.9)%Acquisitions (a)  23,127  —   Total Residential sales  709,099  769,751  (7.9)%          Commercial/Industrial:         Same branch $459,744 $463,527  (0.8)%Acquisitions (a)  277,017  —   Total Commercial/Industrial sales  736,761  463,527  58.9 %Total net sales $1,445,860 $1,233,278  17.2 %          (a) Represents current year impact of acquisitions in their first twelve months                 TopBuild Corp.      Non-GAAP Reconciliations (Unaudited)      (in thousands, except share and per common share amounts)               Three Months Ended March 31,   2026  2025 Gross Profit Reconciliation             Net Sales $1,445,860  $1,233,278        Gross profit, as reported $400,253  $351,473        Acquisition related costs  20   — Rationalization charges  —   13,503 Gross profit, as adjusted $400,273  $364,976        Gross margin, as reported  27.7%   28.5%Gross margin, as adjusted  27.7%  29.6%        Selling, General and Administrative Expense Reconciliation             Selling, general, and administrative expense, as reported $225,210  $173,984        Rationalization charges  —   1,855 Acquisition related costs  2,632   1,300 Selling, general, and administrative expense, as adjusted $222,578  $170,829        Operating Profit Reconciliation             Operating profit, as reported $175,043  $177,489        Rationalization charges  —   15,358 Acquisition related costs  2,652   1,300 Operating profit, as adjusted $177,695  $194,147        Operating margin, as reported  12.1%  14.4%Operating margin, as adjusted  12.3%  15.7%       Income Per Common Share Reconciliation             Income before income taxes, as reported $139,747  $165,973        Rationalization charges  —   15,358 Acquisition related costs  2,652   1,300 Income before income taxes, as adjusted  142,399   182,631        Tax rate at 26.0%  (37,024)  (47,484)Income, as adjusted $105,375  $135,147        Income per common share, as adjusted $3.75  $4.63        Weighted average diluted common shares outstanding  28,130,208   29,174,892         TopBuild Corp.      Reconciliation of Adjusted EBITDA to Net Income (Unaudited)      (in thousands)               Three Months Ended March 31,   2026 2025Net income, as reported $104,813 $123,385Adjustments to arrive at EBITDA, as adjusted:      Interest expense and other, net  35,296  11,516Income tax expense  34,934  42,588Depreciation and amortization  56,295  35,570Share-based compensation  4,629  5,042Rationalization charges  —  15,358Acquisition related costs  2,652  1,300EBITDA, as adjusted $238,619 $234,759        TopBuild Corp.               Acquisition Adjusted Net Sales (Unaudited)              (in thousands)               2025 2026 Trailing Twelve Months Ended Q2 Q3 Q4 Q1 March 31, 2026Net sales$1,297,403 $1,393,158 $1,485,247 $1,445,860 $5,621,668Acquisitions pro forma adjustment † 313,828  199,550  18,046  1,638  533,062Net sales, acquisition adjusted$1,611,231 $1,592,708 $1,503,293 $1,447,498 $6,154,730                              † Sales have been adjusted for the pro forma effect of acquired branches
               
2026-06-12 14:18 2mo ago
2026-05-05 09:01 4mo ago
TopBuild (BLD) Tops Q1 Earnings and Revenue Estimates
BLD Topbuild
FMP Stock News
Original source text
TopBuild (BLD - Free Report) came out with quarterly earnings of $3.75 per share, beating the Zacks Consensus Estimate of $3.64 per share. This compares to earnings of $4.63 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +2.99%. A quarter ago, it was expected that this insulation products company would post earnings of $4.39 per share when it actually produced earnings of $4.5, delivering a surprise of +2.51%.

Over the last four quarters, the company has surpassed consensus EPS estimates four times.

TopBuild, which belongs to the Zacks Building Products - Miscellaneous industry, posted revenues of $1.45 billion for the quarter ended March 2026, surpassing the Zacks Consensus Estimate by 2.06%. This compares to year-ago revenues of $1.23 billion. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

TopBuild shares have added about 3.2% since the beginning of the year versus the S&P 500's gain of 5.2%.

What's Next for TopBuild?While TopBuild has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for TopBuild was unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $4.72 on $1.54 billion in revenues for the coming quarter and $18.12 on $6.09 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Building Products - Miscellaneous is currently in the bottom 23% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Quanex Building Products (NX - Free Report) , another stock in the same industry, has yet to report results for the quarter ended April 2026.

This housing materials maker is expected to post quarterly earnings of $0.38 per share in its upcoming report, which represents a year-over-year change of -36.7%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Quanex Building Products' revenues are expected to be $458.4 million, up 1.3% from the year-ago quarter.
2026-06-12 14:18 2mo ago
2026-05-05 10:36 4mo ago
TopBuild (BLD) Reports Q1 Earnings: What Key Metrics Have to Say
BLD Topbuild
FMP Stock News
Original source text
TopBuild (BLD - Free Report) reported $1.45 billion in revenue for the quarter ended March 2026, representing a year-over-year increase of 17.2%. EPS of $3.75 for the same period compares to $4.63 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $1.42 billion, representing a surprise of +2.06%. The company delivered an EPS surprise of +2.99%, with the consensus EPS estimate being $3.64.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how TopBuild performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Net Sales- Specialty Distribution: $737.08 million compared to the $696.84 million average estimate based on three analysts. The reported number represents a change of +36.2% year over year.Net Sales- Installation Services: $777.33 million compared to the $771.12 million average estimate based on three analysts. The reported number represents a change of +6.4% year over year.Net Sales- Intercompany eliminations: $-68.55 million versus the two-analyst average estimate of $-82.88 million. The reported number represents a year-over-year change of -4.9%.Operating profit, as reported- General corporate expense, net: $-10.67 million versus $-13.15 million estimated by two analysts on average.View all Key Company Metrics for TopBuild here>>>

Shares of TopBuild have returned +19.4% over the past month versus the Zacks S&P 500 composite's +9.5% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
2026-06-12 14:17 2mo ago
2026-05-05 15:02 4mo ago
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Helix Energy Solutions Group, Inc. (NYSE – HLX), TopBuild Corp. (NYSE – BLD), Avanos Medical, Inc. (NYSE – AVNS), Affinity Bancshares (Nasdaq – AFBI)
BLD Topbuild
FMP Stock News
Original source text
BALA CYNWYD, Pa. , May 05, 2026 (GLOBE NEWSWIRE) -- Brodsky and Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith. com) or Marc Ackerman (mackerman@brodskysmith. com) at 855-576-4847.
2026-06-12 14:17 2mo ago
2026-05-06 07:51 4mo ago
Here Are Wednesday’s Top Wall Street Analyst Research Calls: Advanced Micro Devices, American Eagle Outfitters, GlobalFoundries, IAC, Merck, Palantir Technologies, Reddit, and More
BLD Topbuild
FMP Stock News
Original source text
© Chaay_Tee / iStock via Getty Images

Pre-Market Stock Futures: Futures are trading higher on Wednesday as news of an impending end to the Iran war is sending oil prices dramatically lower. This news comes after a bounce-back Tuesday that benefited from lower oil prices, some strong earnings, and solid buying from retail investors. At the same time, hedge funds continue to sell into any market strength. In fact, BTIG reported that the 2nd-largest hedge fund selling of technology stocks in a decade matches the 3rd-largest retail fund flows into the QQQ ETF. With that in mind, the Nasdaq soared to yet another all-time high on Tuesday, closing the day up 1.03% at 25,326, while the S&P 500 also closed at an all-time high on Tuesday, up 0.81% at 7,259. The Dow Jones Industrials checked in with a gain of 0.73% to close at 49,298. The big winner on the day was the small-cap-heavy Russell 2000, which has been the leading index this year, closing up 1.64% at 2,841, and that also was another all-time high.

Treasury Bonds: After hitting some high yields Monday, not seen in months, yields were lower across the Treasury curve as buyers jumped in, especially on longer-dated U.S. debt. While concerns over the potential for inflation to continue to edge higher and the possibility of no interest rate cuts until 2027 continue to hover over the market, 5%+ yields on the 20- and 30-year bonds were too much to ignore. The 30-year long bond finished trading Tuesday at 4.99%, while the benchmark 10-year note was last seen at 4.42%.

Oil and Gas: Some selling across the energy complex was a major positive on Tuesday, as both major benchmarks finished the day lower. The lack of negative news about Iran and the passage of some ships escorted by the U.S. Navy safely through the Strait of Hormuz contributed to lower prices. Brent Crude finished the day at $110.30, down 3.64%, while West Texas Intermediate closed the session at $102.80, down 342%. The last trade for Natural gas was reported at $2.76, down 3.59%. 

Gold: As has been the rule lately, when stock prices go higher, Gold and Silver often follow along in tandem, and that was the case on Tuesday. Gold closed the day higher by 0.76% at $4,556, while Silver was last seen at $72,74, higher by 0.18%. This comes after it was reported that Central Banks from around the world were net sellers of gold in March, with a stunning 30 tonnes of outflows. 

Crypto:
The cryptocurrency market surged, with Bitcoin (BTC) breaking above $80,000 for the first time in three months and reaching $81,500. The rally was powered by more than $500 million in fresh inflows into spot Bitcoin ETFs, robust institutional buying, and growing investor appetite for higher-risk altcoins. The bullish momentum held steady despite persistent geopolitical tensions in the Middle East. At 8 AM EDT, Bitcoin traded at $82,490, while Ethereum was quoted at $2,411.

24/7 Wall St. reviews dozens of analyst research reports daily to identify new investment ideas for both investors and traders. Some of these daily analyst calls cover stocks to buy. Other calls cover stocks to sell or avoid. Remember that no single analyst call should ever be used as a basis to buy or sell a stock. 

Here are some of the top Wall Street analyst upgrades, downgrades, and initiations seen on Wednesday, May 6, 2026.  

Upgrades: Advanced Micro Devices (NASDAQ: AMD | AMD Price Prediction) was upgraded to Buy from Neutral at Goldman Sachs, which launched the target price for the chip giant to $450 from $240. American Eagle Outfitters (NYSE: AEO) was upgraded to Equal Weight from Underweight at Barclays, with a $19 target price. LCI Industries (NYSE: LCII) was raised to Buy from Neutral at Roth Capital, which has a $164 target price for the shares. GlobalFoundries (NYSE: GFS) was raised to Positive from Neutral at Susquehanna, which doubled the target price for the shares to $100 from $50. Palantir Technologies (NASDAQ: PLTR) was raised to Buy from Hold at Argus, which has a $190 target price objective. Downgrades: Abercrombie & Fitch (NYSE: ANF) was downgraded to Underweight from Equal Weight at Barclays, which cut the target price for the retailer to $76 from $95. Coupang (NYSE: CPNG) was downgraded to Neutral from Buy at Citigroup, which trimmed the target price for the stock to $22.20 from $23. IAC  (NYSE: IAC) was downgraded to Hold from Buy at Jefferies, which stays with a $44 target price for the company. Reddit (NYSE: RDDT) was downgraded to Accumulate from Buy at Phillip Securities, which dropped the target price for the stock to $200 from $240. TopBuild (NYSE: BLD) was cut to Hold from Buy at Loop Capital, which kept a $485 target price for the shares. Initiations: Celsius Holdings (NASDAQ: CELH) was initiated with a Neutral rating at Rothschild & Co Redburn, which has a $47 target price for the company. Dakota Gold (NYSE: DC) was initiated with an Outperform rating at CIBC, with an $11 target price. 
Kymera Therapeutics (NASDAQ: KYMR) was started with a Buy rating at Canaccord, with a $106 target price. Merck & Co (NYSE: MRK) was reinstated with a Neutral rating at Citigroup, which has a $125 target price for the pharmaceutical giant.
2026-06-12 14:17 2mo ago
2026-05-14 19:00 3mo ago
Is TopBuild Stock a Hidden Gem? Expert Ratings Inside!
BLD Topbuild
FMP Stock News
Original source text
Explore the exciting world of TopBuild (BLD +0.48%) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!
*Stock prices used were the prices of March 11, 2026. The video was published on May 7, 2026.

Anand Chokkavelu has no position in any of the stocks mentioned. Jason Hall has no position in any of the stocks mentioned. Tyler Crowe has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends TopBuild. The Motley Fool has a disclosure policy.